DIAL CORP /NEW/
8-K, 1997-11-12
SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS
Previous: DURA AUTOMOTIVE SYSTEMS INC, 8-K/A, 1997-11-12
Next: DIAL CORP /NEW/, 424B5, 1997-11-12







                  SECURITIES AND EXCHANGE COMMISSION

                        Washington, D.C. 20549

                               FORM 8-K

                            CURRENT REPORT

                Pursuant to Section 13 or 15(d) of the
                    Securities Exchange Act of 1934



Date of Report: November 10, 1997

Date of Earliest Event Reported: November 10, 1997


                         THE DIAL CORPORATION
        (Exact name of registrant as specified in its charter)

       Delaware                      1-11793                51-0374887 
(State or Other Jurisdiction  (Commission File Number)    (IRS Employee)
     of Incorporation)                                 Identification Number)


15501 North Dial Boulevard, Scottsdale, AZ                  85260-1619       
(Address of principal executive offices)                    (Zip Code)
       
Registrant's telephone number, including area code: (602) 754-3425




Item 5.     Other Events.

            In connection with the offering (the "Offering") by The Dial
Corporation (the "Company") of up to $115,000,000 aggregate offering price of
its Common Stock, par value $.01 per share, pursuant to the Registration
Statement on Form S-3 (File No. 333-33659), as amended (the "Registration
Statement"), which Registration Statement was declared effective on October
16, 1997, the Company is hereby filing as Exhibit 1 hereto the U.S. Purchase
Agreement, dated November 10, 1997 (the "Purchase Agreement"), entered into
by the Company, Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith
Incorporated, J.P. Morgan Securities Inc., NationsBanc Montgomery Securities,
Inc., PaineWebber Incorporated, Prudential Securities Incorporated and Smith
Barney Inc., as representatives of the U.S. underwriters named in Schedule A
thereto.  The Purchase Agreement is hereby incorporated by reference into the
Registration Statement as Exhibit 1.1 thereto.


Item 7.     Financial Statements and Exhibits.

            The following is filed as Exhibit 1 hereto:

            The Purchase Agreement.





                                 SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
behalf of the undersigned hereunto duly authorized.

Dated:  November 11, 1997

                                    THE DIAL CORPORATION



                                    By:  /s/ Lowell L. Robertson
                                         -----------------------------------
                                         Lowell L. Robertson
                                         Senior Vice President, Finance



                             EXHIBIT INDEX


Exhibit No.                      Description
- -----------                      -----------

1                                Purchase Agreement



======================================================================








                         THE DIAL CORPORATION

                       (a Delaware corporation)








                   4,695,751 Shares of Common Stock



                        U.S. PURCHASE AGREEMENT
















Dated:  November 10, 1997


======================================================================




                           TABLE OF CONTENTS
U.S. PURCHASE AGREEMENT...................................................1

      SECTION 1. Representations and Warranties...........................3

            (a) Representations and Warranties by the Company.............3

                     (i) Compliance with Registration Requirements........3
                     (ii) Incorporated Documents..........................4
                     (iii) Independent Accountants........................4
                     (iv) Financial Statements............................4
                     (v) No Material Adverse Change in Business...........4
                     (vi) Good Standing of the Company....................5
                     (vii) Good Standing of Subsidiaries..................5
                     (viii) Capitalization................................5
                     (ix) Authorization of Agreement......................6
                     (x) Authorization and Description of Securities......6
                     (xi) Absence of Defaults and Conflicts...............6
                     (xii) Absence of Labor Dispute.......................6
                     (xiii) Absence of Proceedings........................7
                     (xiv) Accuracy of Exhibits...........................7
                     (xv) Possession of Intellectual Property.............7
                     (xvi) Absence of Further Requirements................7
                     (xvii) Possession of Licenses and Permits............7
                     (xviii) Title to Property............................8
                     (xix) Environmental Laws.............................8
                     (xx) Investment Company Act..........................8
                     (xix) Tax Ruling.....................................8

            (b) Officer's Certificates....................................9

      SECTION 2. Sale and Delivery to U.S. Underwriters; Closing..........9

            (a) Initial Securities........................................9
            (b) Option Securities.........................................9
            (c) Payment...................................................9
            (d) Denominations; Registration..............................10

      SECTION 3. Covenants of the Company................................10

            (a) Compliance  with  Securities  Regulations and
                     Commission Requests.................................10
            (b) Filing of Amendments.....................................11
            (c) Delivery of Registration Statements......................11
            (d) Delivery of Prospectuses.................................11
            (e) Continued Compliance with Securities Laws................11
            (f) Blue Sky Qualifications..................................12
            (g) Rule 158.................................................12
            (h) Listing..................................................12
            (i) Restriction on Sale of Securities........................12
            (j) Reporting Requirements...................................12
            (k) Use of Proceeds..........................................13

      SECTION 4. Payment of Expenses.....................................13

            (a)  Expenses................................................13
            (b) Termination of Agreement.................................13

      SECTION 5. Conditions of U.S. Underwriters' Obligations............13

            (a) Effectiveness of Registration Statement..................13
            (b) Opinion of Counsel for Company...........................13
            (c) Opinion of Counsel for U.S. Underwriters.................14
            (d) Officers' Certificate....................................14
            (e) Accountants' Comfort Letter..............................14
            (f) Bring-down Comfort Letter................................14
            (g) Approval of Listing......................................15
            (h) Lock-up Agreements.......................................15
            (i) Purchase of Initial International Securities.............15
            (j) Conditions to Purchase of U.S. Option Securities.........15
            (k) Additional Documents.....................................16
            (l) Termination of Agreement.................................16

      SECTION 6. Indemnification.........................................16

            (a) Indemnification of U.S. Underwriters.....................16
            (b) Indemnification of Company, Directors and Officers.......17
            (c) Actions against Parties; Notification....................17
            (d) Settlement without Consent if Failure to Reimburse.......18

      SECTION 7. Contribution............................................18

      SECTION 8.  Representations,  Warranties and Agreements to 
            Survive Delivery.............................................19

      SECTION 9. Termination of Agreement................................19

            (a) Termination; General.....................................19
            (b) Liabilities..............................................19

      SECTION 10.  Default by One or More of the U.S. Underwriters.......20

      SECTION 11.  Notices...............................................20

      SECTION 12.  Parties...............................................20

      SECTION 13.  GOVERNING LAW AND TIME................................21

      SECTION 14.  Effect of Headings....................................21




SCHEDULES
      Schedule  A - List of U.S. Underwriters.......................Sch A-1
      Schedule  B - Pricing Information.............................Sch B-1
      Schedule  C - List of Subsidiaries............................Sch C-1
      Schedule  D - List of Persons and Entities 
                       Subject to Lock-up...........................Sch D-1

EXHIBITS
      Exhibit  A-1 - Form of Opinion of Company's Counsel...........   A1-1
      Exhibit  A-2 - Form of Opinion of Company's In-House 
                        Counsel.....................................   A2-1
      Exhibit  B - Form of Lock-up Letter...........................    B-1

ANNEXES
      Annex  A - Form of Accountants' Comfort Letter............  Annex A-1



                         The Dial Corporation
                       (a Delaware corporation)

                   4,695,751 Shares of Common Stock
                      (Par Value $.01 Per Share)

                        U.S. PURCHASE AGREEMENT

                                                     November 10, 1997

MERRILL LYNCH & CO.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
J.P. Morgan Securities Inc.
NationsBanc Mongtomery Securities, Inc.
PaineWebber Incorporated
Prudential Securities Incorporated
Smith Barney Inc.
as U.S. Representatives of the several U.S. Underwriters
c/o Merrill Lynch & Co.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
North Tower
World Financial Center
New York, New York   10281

Ladies and Gentlemen:

     The Dial Corporation, a Delaware corporation (the "Company"),
confirms its agreement with Merrill Lynch & Co., Merrill Lynch,
Pierce, Fenner & Smith ("Merrill Lynch") and each of the other U.S.
Underwriters named in Schedule A hereto (collectively, the "U.S.
Underwriters", which term shall also include any underwriter
substituted as hereinafter provided in Section 10 hereof), for whom
Merrill Lynch, J.P. Morgan Securities Inc., NationsBanc Montgomery
Securities, Inc., PaineWebber Incorporated, Prudential Securities
Incorporated and Smith Barney Inc. are acting as representatives (in
such capacity, the "U.S. Representatives"), with respect to the issue
and sale by the Company and the purchase by the U.S. Underwriters,
acting severally and not jointly, of the respective numbers of shares
of Common Stock, par value $.01 per share, of the Company ("Common
Stock") set forth in said Schedule A, and with respect to the grant by
the Company to the U.S. Underwriters, acting severally and not
jointly, of the option described in Section 2(b) hereof to purchase
all or any part of 704,362 additional shares of Common Stock to cover
over-allotments, if any. The aforesaid 4,695,751 shares of Common
Stock (the "Initial U.S. Securities") to be purchased by the U.S.
Underwriters and all or any part of the 704,362 shares of Common Stock
subject to the option described in Section 2(b) hereof (the "U.S.
Option Securities") are hereinafter called, collectively, the "U.S.
Securities".

     It is understood that the Company is concurrently entering into
an agreement dated the date hereof (the "International Purchase
Agreement") providing for the offering by the Company of an aggregate
of 765,000 shares of Common Stock (the "Initial International
Securities") outside the United States and Canada through arrangements
with Merrill Lynch International, J.P. Morgan Securities Ltd.,
NationsBanc Montgomery Securities, Inc., PaineWebber International
(U.K.) Ltd., Prudential-Bache Securities (U.K.) Inc. and Smith Barney
Inc. (the "International Managers") and the grant by the Company to
the International Managers, acting severally and not jointly, of an
option to purchase all or any part of the International Managers' pro
rata portion of up to 114,750 additional shares of Common Stock solely
to cover over-allotments, if any (the "International Option
Securities" and, together with the U.S. Option Securities, the "Option
Securities"). The Initial International Securities and the
International Option Securities are hereinafter called the
"International Securities". It is understood that the Company is not
obligated to sell and the U.S. Underwriters are not obligated to
purchase, any Initial U.S. Securities unless all of the Initial
International Securities are contemporaneously purchased by the
International Managers.

     The U.S. Underwriters and the International Managers are
hereinafter collectively called the "Underwriters", the Initial U.S.
Securities and the Initial International Securities are hereinafter
collectively called the "Initial Securities", and the U.S. Securities
and the International Securities are hereinafter collectively called
the "Securities".

     The Underwriters will concurrently enter into an Intersyndicate
Agreement of even date herewith (the "Intersyndicate Agreement")
providing for the coordination of certain transactions among the
Underwriters under the direction of Merrill Lynch (in such capacity,
the "Global Coordinator").

     The Company understands that the U.S. Underwriters propose to
make a public offering of the U.S. Securities as soon as the U.S.
Representatives deem advisable after this Agreement has been executed
and delivered. The price per share of the International Securities to
be purchased by the International Managers shall be identical to the
price per share for the U.S. Securities to be purchased by the U.S.
Underwriters hereunder.

     The Company has filed with the Securities and Exchange Commission
(the "Commission") a registration statement on Form S-3 (No.
333-33659), including the related preliminary prospectus or
prospectuses, covering the registration of the Securities under the
Securities Act of 1933, as amended (the "1933 Act"), and the offering
thereof from time to time in accordance with Rule 415 of the rules and
regulations of the Commission under the 1933 Act (the "1933 Act
Regulations"). As provided in Section 3(a), a prospectus supplement
relating to the Securities, the terms of the offering thereof and the
other matters set forth therein has been prepared and will be filed
pursuant to Rule 424 of the 1933 Act Regulations. Such prospectus
supplement, in the form first filed after the date hereof pursuant to
Rule 424, is herein referred to as the "Prospectus Supplement." The
prospectus included in the Registration Statement relating to all
offerings of Securities under the Registration Statement, as
supplemented by the Prospectus Supplement, is herein called the
"Prospectus;" PROVIDED, HOWEVER, that, if the Prospectus is amended or
supplemented on or after the date hereof but prior to the date on
which the Prospectus Supplement is first filed pursuant to Rule 424,
the term "Prospectus" shall refer to the Prospectus as so amended or
supplemented and as supplemented by the Prospectus Supplement; and
PROVIDED, FURTHER, that all references to the "Registration Statement"
and the "Prospectus" shall be deemed to include all documents
incorporated therein by reference pursuant to the Securities Exchange
Act of 1934, as amended (the "1934 Act"); and PROVIDED, FURTHER, that
if the Company files a registration statement with the Commission
pursuant to Rule 462(b) of the 1933 Act Regulations (the "Rule 462(b)
Registration Statement"), then, after such filing, all references to
the "Registration Statement" shall also be deemed to include the Rule
462(b) Registration Statement. Two forms of Prospectus (as defined
below) are to be used in connection with the offering and sale of the
Securities: one relating to the U.S. Securities (the "Form of U.S.
Prospectus") and one relating to the International Securities (the
"Form of International Prospectus"). The Form of International
Prospectus is identical to the Form of U.S. Prospectus, except for the
front cover and back cover pages and the information under the caption
"Underwriting" and the inclusion in the Form of International
Prospectus of a section under the caption "Certain United States Tax
Considerations for Non-United States Holders." Each Form of U.S.
Prospectus used before such registration statement became effective,
and any Form of U.S. Prospectus that was used after such effectiveness
and prior to the execution and delivery of this Agreement, together
with any Form of International Prospectus of even date therewith
relating to the International Securities, is herein called a
"preliminary prospectus." Any registration statement filed pursuant to
Rule 462(b) of the 1933 Act Regulations is herein referred to as the
"Rule 462(b) Registration Statement," and after such filing the term
"Registration Statement" shall include the Rule 462(b) Registration
Statement. The final Form of U.S. Prospectus, including the documents
incorporated by reference therein pursuant to Item 12 of Form S-3, and
the final Form of International Prospectus, including the documents
incorporated by reference therein, in each case in the forms first
furnished to the Underwriters for use in connection with the offering
of the Securities, are herein called the "U.S. Prospectus" and the
"International Prospectus," respectively, and collectively, the
"Prospectuses." For purposes of this Agreement, all references to the
Registration Statement, any U.S. preliminary prospectus, the U.S.
Prospectus, or any Term Sheet or any amendment or supplement to any of
the foregoing shall be deemed to include the copy filed with the
Commission pursuant to its Electronic Data Gathering, Analysis and
Retrieval system ("EDGAR").

     All references in this Agreement to financial statements and
schedules and other information which is "contained," "included" or
"stated" in the Registration Statement, any preliminary prospectus
(including the Form of U.S. Prospectus and Form of International
Prospectus) or the Prospectuses (or other references of like import)
shall be deemed to mean and include all such financial statements and
schedules and other information which is incorporated by reference in
the Registration Statement, any preliminary prospectus (including the
Form of U.S. Prospectus and Form of International Prospectus) or the
Prospectuses, as the case may be; and all references in this Agreement
to amendments or supplements to the Registration Statement, any
preliminary prospectus or the Prospectuses shall be deemed to mean and
include the filing of any document under the 1934 Act which is
incorporated by reference in the Registration Statement, such
preliminary prospectus or the Prospectuses, as the case may be.




     SECTION 1. Representations and Warranties.
                ------------------------------

     (a) REPRESENTATIONS AND WARRANTIES BY THE COMPANY. The Company
represents and warrants to each U.S. Underwriter as of the date
hereof, as of the Closing Time referred to in Section 2(c) hereof, and
as of each Date of Delivery (if any) referred to in Section 2(b)
hereof, and agrees with each U.S. Underwriter, as follows:

          (i) Compliance with Registration Requirements. The Company
     meets the requirements for use of Form S-3 under the 1933 Act.
     Each of the Registration Statement and any Rule 462(b)
     Registration Statement has become effective under the 1933 Act
     and no stop order suspending the effectiveness of the
     Registration Statement or any Rule 462(b) Registration Statement
     has been issued under the 1933 Act and no proceedings for that
     purpose have been instituted or are pending or, to the knowledge
     of the Company, are contemplated by the Commission, and any
     request on the part of the Commission for additional information
     has been complied with.

          At the respective times the Registration Statement, any Rule
     462(b) Registration Statement and any post-effective amendments
     thereto became effective and at the Closing Time (and, if any
     U.S. Option Securities are purchased, at the Date of Delivery),
     the Registration Statement, the Rule 462(b) Registration
     Statement and any amendments and supplements thereto complied and
     will comply in all material respects with the requirements of the
     1933 Act and the 1933 Act Regulations and did not and will not
     contain an untrue statement of a material fact or omit to state a
     material fact required to be stated therein or necessary to make
     the statements therein not misleading. Neither of the
     Prospectuses nor any amendments or supplements thereto, at the
     time such Prospectuses or any amendments or supplements thereto
     were issued and at the Closing Time (and, if any U.S. Option
     Securities are purchased, at the Date of Delivery), included or
     will include an untrue statement of a material fact or omitted or
     will omit to state a material fact necessary in order to make the
     statements therein, in the light of the circumstances under which
     they were made, not misleading. The representations and
     warranties in this subsection shall not apply to statements in or
     omissions from the Registration Statement or the U.S. Prospectus
     made in reliance upon and in conformity with information
     furnished to the Company in writing by any U.S. Underwriter
     through the U.S. Representatives expressly for use in the
     Registration Statement or the U.S. Prospectus.

          Each U.S. preliminary prospectus and the prospectuses filed
     as part of the Registration Statement as originally filed or as
     part of any amendment thereto, or filed pursuant to Rule 424
     under the 1933 Act, complied when so filed in all material
     respects with the 1933 Act Regulations and each U.S. preliminary
     prospectus and the U.S. Prospectus delivered to the Underwriters
     for use in connection with this offering was identical to the
     electronically transmitted copies thereof filed with the
     Commission pursuant to EDGAR, except to the extent permitted by
     Regulation S-T.

          (ii) Incorporated Documents. The documents incorporated or
     deemed to be incorporated by reference in the Registration
     Statement and the Prospectuses, at the time they were or
     hereafter are filed with the Commission, complied and will comply
     in all material respects with the requirements of the 1934 Act
     and the rules and regulations of the Commission thereunder (the
     "1934 Act Regulations"), and, when read together with the other
     information in the Prospectuses, at the time the Registration
     Statement became effective, at the time the Prospectuses were
     issued and at the Closing Time (and, if any U.S. Option
     Securities are purchased, at the Date of Delivery), did not and
     will not contain an untrue statement of a material fact or omit
     to state a material fact required to be stated therein or
     necessary to make the statements therein not misleading.

          (iii) Independent Accountants. The accountants who certified
     the financial statements and supporting schedules included in the
     Registration Statement are independent public accountants as
     required by the 1933 Act and the 1933 Act Regulations.

          (iv) Financial Statements. The financial statements included
     in the Registration Statement and the Prospectuses, together with
     the related schedules and notes, present fairly the financial
     position of the Company and its consolidated subsidiaries at the
     dates indicated and the statement of operations, stockholders'
     equity and cash flows of the Company and its consolidated
     subsidiaries for the periods specified; said financial statements
     have been prepared in conformity with generally accepted
     accounting principles ("GAAP") applied on a consistent basis
     throughout the periods involved. The supporting schedules, if
     any, included in the Registration Statement present fairly in
     accordance with GAAP the information required to be stated
     therein. The selected financial data and the summary financial
     information included in the Prospectuses present fairly the
     information shown therein and have been compiled on a basis
     consistent with that of the audited financial statements included
     in the Registration Statement.

          (v) No Material Adverse Change in Business. Since the
     respective dates as of which information is given in the
     Registration Statement and the Prospectuses, except as otherwise
     stated therein, (A) there has been no material adverse change in
     the condition, financial or otherwise, or in the earnings,
     business affairs or business prospects of the Company and its
     subsidiaries considered as one enterprise, whether or not arising
     in the ordinary course of business (a "Material Adverse Effect"),
     (B) there have been no transactions entered into by the Company
     or any of its subsidiaries, other than those in the ordinary
     course of business, which are material with respect to the
     Company and its subsidiaries considered as one enterprise, and
     (C) except for dividends on the Common Stock of $0.08 per share
     in each of the third and fourth quarters of 1996 and the first,
     second and third quarters of 1997, there has been no dividend or
     distribution of any kind declared, paid or made by the Company on
     any class of its capital stock.

          (vi) Good Standing of the Company. The Company has been duly
     organized and is validly existing as a corporation in good
     standing under the laws of the State of Delaware and has
     corporate power and authority to own, lease and operate its
     properties and to conduct its business as described in the
     Prospectuses and to enter into and perform its obligations under
     this Agreement and the International Purchase Agreement; and the
     Company is duly qualified as a foreign corporation to transact
     business and is in good standing in each other jurisdiction in
     which such qualification is required, whether by reason of the
     ownership or leasing of property or the conduct of business,
     except where the failure so to qualify or to be in good standing
     would not result in a Material Adverse Effect.

          (vii) Good Standing of Subsidiaries. Each "significant
     subsidiary" of the Company (as such term is defined in Rule 1-02
     of Regulation S-X) (each a "Subsidiary" and, collectively, the
     "Subsidiaries") has been duly organized and is validly existing
     as a corporation in good standing under the laws of the
     jurisdiction of its incorporation, has corporate power and
     authority to own, lease and operate its properties and to conduct
     its business as described in the Prospectuses and is duly
     qualified as a foreign corporation to transact business and is in
     good standing in each jurisdiction in which such qualification is
     required, whether by reason of the ownership or leasing of
     property or the conduct of business, except where the failure so
     to qualify or to be in good standing would not result in a
     Material Adverse Effect; except as otherwise disclosed in the
     Registration Statement, all of the issued and outstanding capital
     stock of each such Subsidiary has been duly authorized and
     validly issued, is fully paid and non-assessable and is owned by
     the Company, directly or through subsidiaries, free and clear of
     any security interest, mortgage, pledge, lien, encumbrance, claim
     or equity; none of the outstanding shares of capital stock of any
     Subsidiary was issued in violation of the preemptive or similar
     rights of any securityholder of such Subsidiary. The only
     subsidiaries of the Company are (a) the subsidiaries listed on
     Schedule C hereto and (b) certain other subsidiaries which,
     considered in the aggregate as a single Subsidiary, do not
     constitute a "significant subsidiary" as defined in Rule 1-02 of
     Regulation S-X. The Company has no "significant subsidiaries" (as
     such term is defined in Rule 1-02 of Regulation S-X).

          (viii) Capitalization. The authorized, issued and
     outstanding capital stock of the Company is as set forth in the
     Prospectuses in the column entitled "Actual" under the caption
     "Capitalization" (except for subsequent issuances, if any,
     pursuant to this Agreement or the International Purchase
     Agreement, pursuant to reservations, agreements or employee
     benefit plans referred to in the Prospectuses or pursuant to the
     exercise of convertible securities or options referred to in the
     Prospectuses). The shares of issued and outstanding capital stock
     of the Company have been duly authorized and validly issued and
     are fully paid and non-assessable; none of the outstanding shares
     of capital stock of the Company was issued in violation of the
     preemptive or other similar rights of any securityholder of the
     Company.

          (ix) Authorization of Agreement. This Agreement and the
     International Purchase Agreement have been duly authorized,
     executed and delivered by the Company.

          (x) Authorization and Description of Securities. The
     Securities to be purchased by the U.S. Underwriters and the
     International Managers from the Company have been duly authorized
     for issuance and sale to the U.S. Underwriters pursuant to this
     Agreement and the International Managers pursuant to the
     International Purchase Agreement, respectively, and, when issued
     and delivered by the Company pursuant to this Agreement and the
     International Purchase Agreement, respectively, against payment
     of the consideration set forth herein and in the International
     Purchase Agreement, respectively, will be validly issued, fully
     paid and non-assessable; the Common Stock conforms in all
     material respects to the statements relating thereto contained in
     the Prospectuses and such description conforms in all material
     respects to the rights set forth in the instruments defining the
     same; no holder of the Securities will be subject to personal
     liability by reason of being such a holder; and the issuance of
     the Securities is not subject to the preemptive or other similar
     rights of any securityholder of the Company.

          (xi) Absence of Defaults and Conflicts. Neither the Company
     nor any of its subsidiaries is in violation of its charter or
     by-laws or in default in the performance or observance of any
     obligation, agreement, covenant or condition contained in any
     contract, indenture, mortgage, deed of trust, loan or credit
     agreement, note, lease or other agreement or instrument to which
     the Company or any of its subsidiaries is a party or by which it
     or any of them may be bound, or to which any of the property or
     assets of the Company or any subsidiary is subject (collectively,
     "Agreements and Instruments") except for such defaults that would
     not result in a Material Adverse Effect; and the execution,
     delivery and performance of this Agreement and the International
     Purchase Agreement and the consummation of the transactions
     contemplated in this Agreement, the International Purchase
     Agreement and in the Registration Statement (including the
     issuance and sale of the Securities and the use of the proceeds
     from the sale of the Securities as described in the Prospectuses
     under the caption "Use of Proceeds") and compliance by the
     Company with its obligations under this Agreement and the
     International Purchase Agreement have been duly authorized by all
     necessary corporate action and do not and will not, whether with
     or without the giving of notice or passage of time or both,
     conflict with or constitute a breach of, or default or Repayment
     Event (as defined below) under, or result in the creation or
     imposition of any lien, charge or encumbrance upon any property
     or assets of the Company or any subsidiary pursuant to, the
     Agreements and Instruments (except for such conflicts, breaches
     or defaults or liens, charges or encumbrances that would not
     result in a Material Adverse Effect), nor will such action result
     in any violation of the provisions of the charter or by-laws of
     the Company or any subsidiary or any existing applicable law,
     statute, rule, regulation, judgment, order, writ or decree of any
     government, government instrumentality or court, domestic or
     foreign, having jurisdiction over the Company or any subsidiary
     or any of their assets, properties or operations (except for such
     violations of laws, statutes, rules, regulations, judgments,
     orders, writs or decrees that would not result in a Material
     Adverse Effect). As used herein, a "Repayment Event" means any
     event or condition which gives the holder of any note, debenture
     or other evidence of indebtedness (or any person acting on such
     holder's behalf) the right to require the repurchase, redemption
     or repayment of all or a portion of such indebtedness by the
     Company or any subsidiary.

          (xii) Absence of Labor Dispute. No labor dispute with the
     employees of the Company or any subsidiary exists or, to the
     knowledge of the Company, is imminent, and the Company is not
     aware of any existing or imminent labor disturbance by the
     employees of any of its or any subsidiary's principal suppliers,
     manufacturers, customers or contractors, which, in either case,
     may reasonably be expected to result in a Material Adverse
     Effect.

          (xiii) Absence of Proceedings. There is no action, suit,
     proceeding, inquiry or investigation before or brought by any
     court or governmental agency or body, domestic or foreign, now
     pending, or, to the knowledge of the Company, threatened, against
     or affecting the Company or any subsidiary, which is required to
     be disclosed in the Registration Statement (other than as
     disclosed therein), or which might reasonably be expected to
     result in a Material Adverse Effect, or which might reasonably be
     expected to materially and adversely affect the properties or
     assets thereof or the consummation of the transactions
     contemplated in this Agreement and the International Purchase
     Agreement or the performance by the Company of its obligations
     hereunder or thereunder; the aggregate of all pending legal or
     governmental proceedings to which the Company or any subsidiary
     is a party or of which any of their respective property or assets
     is the subject which are not described in the Registration
     Statement, including ordinary routine litigation incidental to
     the business, could not reasonably be expected to result in a
     Material Adverse Effect.

          (xiv) Accuracy of Exhibits. There are no contracts or
     documents which are required to be described in the Registration
     Statement, the Prospectuses or the documents incorporated by
     reference therein or to be filed as exhibits thereto which have
     not been so described and filed as required.

          (xv) Possession of Intellectual Property. The Company and
     its subsidiaries own or possess, or can acquire on reasonable
     terms, adequate patents, patent rights, licenses, inventions,
     copyrights, know-how (including trade secrets and other
     unpatented and/or unpatentable proprietary or confidential
     information, systems or procedures), trademarks, service marks,
     trade names or other intellectual property (collectively,
     "Intellectual Property") necessary to carry on the business now
     operated by them, and neither the Company nor any of its
     subsidiaries has received any notice or is otherwise aware of any
     infringement of or conflict with asserted rights of others with
     respect to any Intellectual Property or of any facts or
     circumstances which would render any Intellectual Property
     invalid or inadequate to protect the interest of the Company or
     any of its subsidiaries therein, and which infringement or
     conflict (if the subject of any unfavorable decision, ruling or
     finding) or invalidity or inadequacy, singly or in the aggregate,
     would result in a Material Adverse Effect.

          (xvi) Absence of Further Requirements. No filing with, or
     authorization, approval, consent, license, order, registration,
     qualification or decree of, any court or governmental authority
     or agency is necessary or required for the performance by the
     Company of its obligations hereunder, in connection with the
     offering, issuance or sale of the Securities under this Agreement
     and the International Purchase Agreement or the consummation of
     the transactions contemplated by this Agreement and the
     International Purchase Agreement, except such as have been
     already obtained or as may be required under the 1933 Act or the
     1933 Act Regulations and foreign or state securities or blue sky
     laws.

          (xvii) Possession of Licenses and Permits. The Company and
     its subsidiaries possess such permits, licenses, approvals,
     consents and other authorizations (collectively, "Governmental
     Licenses") issued by the appropriate federal, state, local or
     foreign regulatory agencies or bodies necessary to conduct the
     business now operated by them; the Company and its subsidiaries
     are in compliance with the terms and conditions of all such
     Governmental Licenses, except where the failure so to comply
     would not, singly or in the aggregate, have a Material Adverse
     Effect; all of the Governmental Licenses are valid and in full
     force and effect, except when the invalidity of such Governmental
     Licenses or the failure of such Governmental Licenses to be in
     full force and effect would not have a Material Adverse Effect;
     and neither the Company nor any of its subsidiaries has received
     any notice of proceedings relating to the revocation or
     modification of any such Governmental Licenses which, singly or
     in the aggregate, if the subject of an unfavorable decision,
     ruling or finding, would result in a Material Adverse Effect.

          (xviii) Title to Property. The Company and its subsidiaries
     have good and marketable title to all real property owned by the
     Company and its subsidiaries and good title to all other
     properties owned by them, in each case, free and clear of all
     mortgages, pledges, liens, security interests, claims,
     restrictions or encumbrances of any kind except such as (a) are
     described in the Prospectuses or (b) do not, singly or in the
     aggregate, materially affect the value of such property in the
     aggregate and do not interfere with the use made and proposed to
     be made of such property in the aggregate by the Company or any
     of its subsidiaries; and all of the leases and subleases material
     to the business of the Company and its subsidiaries, considered
     as one enterprise, and under which the Company or any of its
     subsidiaries holds properties described in the Prospectuses, are
     in full force and effect, and neither the Company nor any
     subsidiary has any notice of any material claim of any sort that
     has been asserted by anyone adverse to the rights of the Company
     or any subsidiary under any of the leases or subleases mentioned
     above, or affecting or questioning the rights of the Company or
     such subsidiary to the continued possession of the leased or
     subleased premises under any such lease or sublease.

          (xix) Environmental Laws. Except as described in the
     Registration Statement and except as would not, singly or in the
     aggregate, result in a Material Adverse Effect, (A) neither the
     Company nor any of its subsidiaries is in violation of any
     federal, state, local or foreign statute, law, rule, regulation,
     ordinance, code, policy or rule of common law or any judicial or
     administrative interpretation thereof, including any judicial or
     administrative order, consent, decree or judgment, relating to
     pollution or protection of human health, the environment
     (including, without limitation, ambient air, surface water,
     groundwater, land surface or subsurface strata) or wildlife,
     including, without limitation, laws and regulations relating to
     the release or threatened release of chemicals, pollutants,
     contaminants, wastes, toxic substances, hazardous substances,
     petroleum or petroleum products (collectively, "Hazardous
     Materials") or to the manufacture, processing, distribution, use,
     treatment, storage, disposal, transport or handling of Hazardous
     Materials (collectively, "Environmental Laws"), (B) the Company
     and its subsidiaries have all permits, authorizations and
     approvals required under any applicable Environmental Laws and
     are each in compliance with their requirements, (C) there are no
     pending or threatened administrative, regulatory or judicial
     actions, suits, demands, demand letters, claims, liens, notices
     of noncompliance or violation, investigation or proceedings
     relating to any Environmental Law against the Company or any of
     its subsidiaries and (D) there are no events or circumstances
     that might reasonably be expected to form the basis of an order
     for clean-up or remediation, or an action, suit or proceeding by
     any private party or governmental body or agency, against or
     affecting the Company or any of its subsidiaries relating to
     Hazardous Materials or any Environmental Laws.

          (xx) Investment Company Act. The Company is not, and upon
     the issuance and sale of the Securities as herein contemplated
     and the application of the net proceeds therefrom as described in
     the Prospectus will not be, an "investment company" or an entity
     "controlled" by an "investment company" as such terms are defined
     in the Investment Company Act of 1940, as amended (the "1940
     Act").

          (xxi) Tax Ruling. Viad Corp. (formerly known as The Dial
     Corp.) ("Former Parent") has received a tax ruling (the "Tax
     Ruling") from the Internal Revenue Service to the effect that,
     among other things, the distribution of the outstanding stock of
     the Company in August 1996 to the then stockholders of Former
     Parent (the "Distribution") qualifies as a tax-free distribution
     under Section 355 of the Internal Revenue Code of 1986 (the
     "Code"), as amended. Neither the Company nor any of its
     subsidiaries has taken any action or omitted to take any action
     which may reasonably be expected to cause the Distribution to
     fail to qualify under Section 355 of the Code. The Tax Ruling is
     still effective and the Company is not aware of any event or
     condition which may reasonably be expected to cause the Internal
     Revenue Service to reverse the Tax Ruling or which may reasonably
     be expected to cause the Distribution to fail to qualify under
     Section 355 of the Code.

     (b) OFFICER'S CERTIFICATES. Any certificate signed by any officer
of the Company or any of its subsidiaries and delivered to the Global
Coordinator, the U.S. Representatives or to counsel for the U.S.
Underwriters pursuant to this Agreement shall be deemed a
representation and warranty by the Company to each U.S. Underwriter as
to the matters covered thereby.

     SECTION 2. Sale and Delivery to U.S. Underwriters; Closing.
                -----------------------------------------------

     (a) INITIAL SECURITIES. On the basis of the representations and
warranties herein contained and subject to the terms and conditions
herein set forth, the Company agrees to sell to each U.S. Underwriter,
severally and not jointly, and each U.S. Underwriter, severally and
not jointly, agrees to purchase from the Company, at the price per
share set forth in Schedule B, the number of Initial U.S. Securities
set forth in Schedule A opposite the name of such U.S. Underwriter,
plus any additional number of Initial U.S. Securities which such
Underwriter may become obligated to purchase pursuant to the
provisions of Section 10 hereof.

     (b) OPTION SECURITIES. In addition, on the basis of the
representations and warranties herein contained and subject to the
terms and conditions herein set forth, the Company hereby grants an
option to the U.S. Underwriters, severally and not jointly, to
purchase up to an additional 765,000 shares of Common Stock at the
price per share set forth in Schedule B, less an amount per share
equal to any dividends or distributions declared by the Company and
payable on the Initial U.S. Securities but not payable on the U.S.
Option Securities. The option hereby granted will expire 30 days after
the date hereof and may be exercised in whole or in part from time to
time only for the purpose of covering over-allotments which may be
made in connection with the offering and distribution of the Initial
U.S. Securities upon notice by the Global Coordinator to the Company
setting forth the number of U.S. Option Securities as to which the
several U.S. Underwriters are then exercising the option and the time
and date of payment and delivery for such U.S. Option Securities. Any
such time and date of delivery for the U.S. Option Securities (a "Date
of Delivery") shall be determined by the Global Coordinator, but shall
not be later than seven full business days after the exercise of said
option, nor in any event prior to the Closing Time, as hereinafter
defined. If the option is exercised as to all or any portion of the
U.S. Option Securities, each of the U.S. Underwriters, acting
severally and not jointly, will purchase that proportion of the total
number of U.S. Option Securities then being purchased which the number
of Initial U.S. Securities set forth in Schedule A opposite the name
of such U.S. Underwriter bears to the total number of Initial U.S.
Securities, subject in each case to such adjustments as the Global
Coordinator in its discretion shall make to eliminate any sales or
purchases of fractional shares.

     (c) PAYMENT. Payment of the purchase price for, and delivery of
certificates for, the Initial Securities shall be made at the offices
of Shearman & Sterling, 599 Lexington Avenue, New York, New York
10022-6069, or at such other place as shall be agreed upon by the
Global Coordinator and the Company, at 9:00 A.M. (Eastern time) on the
third (fourth, if the pricing occurs after 4:30 P.M. (Eastern time) on
any given day) business day after the date hereof (unless postponed in
accordance with the provisions of Section 10), or such other time not
later than ten business days after such date as shall be agreed upon
by the Global Coordinator and the Company (such time and date of
payment and delivery being herein called "Closing Time").

     In addition, in the event that any or all of the U.S. Option
Securities are purchased by the U.S. Underwriters, payment of the
purchase price for, and delivery of certificates for, such U.S. Option
Securities shall be made at the above-mentioned offices, or at such
other place as shall be agreed upon by the Global Coordinator and the
Company, on each Date of Delivery as specified in the notice from the
Global Coordinator to the Company.

     Payment shall be made to the Company by wire transfer of
immediately available funds to a bank account designated by the
Company, against delivery to the U.S. Representatives for the
respective accounts of the U.S. Underwriters of certificates for the
U.S. Securities to be purchased by them. It is understood that each
U.S. Underwriter has authorized the U.S. Representatives, for its
account, to accept delivery of, receipt for, and make payment of the
purchase price for, the Initial U.S. Securities and the U.S. Option
Securities, if any, which it has agreed to purchase. Merrill Lynch,
individually and not as representative of the U.S. Underwriters, may
(but shall not be obligated to) make payment of the purchase price for
the Initial U.S. Securities or the U.S. Option Securities, if any, to
be purchased by any U.S. Underwriter whose funds have not been
received by the Closing Time or the relevant Date of Delivery, as the
case may be, but such payment shall not relieve such U.S. Underwriter
from its obligations hereunder.

     (d) DENOMINATIONS; REGISTRATION. Certificates for the Initial
U.S. Securities and the U.S. Option Securities, if any, shall be in
such denominations and registered in such names as the U.S.
Representatives may request in writing at least one full business day
before the Closing Time or the relevant Date of Delivery, as the case
may be. The certificates for the Initial U.S. Securities and the U.S.
Option Securities, if any, will be made available for examination and
packaging by the U.S. Representatives in The City of New York not
later than 10:00 A.M. (Eastern time) on the business day prior to the
Closing Time or the relevant Date of Delivery, as the case may be.

     SECTION 3. Covenants of the Company. The Company covenants with
each U.S. Underwriter as follows:

          (a) COMPLIANCE WITH SECURITIES REGULATIONS AND COMMISSION
     REQUESTS. The Company, subject to Section 3(b), will comply with
     the requirements of Rule 430A and will notify the Global
     Coordinator immediately, and confirm the notice in writing, (i)
     when any post-effective amendment to the Registration Statement
     shall become effective, or any supplement to the Prospectuses or
     any amended Prospectuses shall have been filed, (ii) of the
     receipt of any comments from the Commission, (iii) of any request
     by the Commission for any amendment to the Registration Statement
     or any amendment or supplement to the Prospectuses or for
     additional information, and (iv) of the issuance by the
     Commission of any stop order suspending the effectiveness of the
     Registration Statement or of any order preventing or suspending
     the use of any preliminary prospectus, or of the initiation or
     threatening of any proceedings for any of such purposes. The
     Company will promptly effect the filings necessary pursuant to
     Rule 424(b) and will take such steps as it deems necessary to
     ascertain promptly whether the form of prospectus transmitted for
     filing under Rule 424(b) was received for filing by the
     Commission and, in the event that it was not, it will promptly
     file such prospectus. The Company will make every reasonable
     effort to prevent the issuance of any stop order and, if any stop
     order is issued, to obtain the lifting thereof at the earliest
     possible moment.

          (b) FILING OF AMENDMENTS. The Company will give the Global
     Coordinator notice of its intention to file or prepare any
     amendment to the Registration Statement (including any filing
     under Rule 462(b)), any Term Sheet or any amendment, supplement
     or revision to either any prospectus included in the Registration
     Statement at the time it became effective or to the Prospectuses,
     whether pursuant to the 1933 Act, the 1934 Act or otherwise, will
     furnish the Global Coordinator with copies of any such documents
     a reasonable amount of time prior to such proposed filing or use,
     as the case may be, and will not file or use any such document to
     which the Global Coordinator or counsel for the U.S. Underwriters
     shall object.

          (c) DELIVERY OF REGISTRATION STATEMENTS. The Company has
     furnished or will deliver to the U.S. Representatives and counsel
     for the U.S. Underwriters, without charge, copies of the
     Registration Statement as originally filed and of each amendment
     thereto (including exhibits filed therewith or incorporated by
     reference therein and documents incorporated or deemed to be
     incorporated by reference therein) and signed copies of all
     consents and certificates of experts. The copies of the
     Registration Statement and each amendment thereto furnished to
     the U.S. Underwriters will be identical to the electronically
     transmitted copies thereof filed with the Commission pursuant to
     EDGAR, except to the extent permitted by Regulation S-T.

          (d) DELIVERY OF PROSPECTUSES. The Company has delivered to
     each U.S. Underwriter, without charge, as many copies of each
     preliminary prospectus as such U.S. Underwriter reasonably
     requested, and the Company hereby consents to the use of such
     copies for purposes permitted by the 1933 Act. The Company will
     furnish to each U.S. Underwriter, without charge, during the
     period when the U.S. Prospectus is required to be delivered under
     the 1933 Act or the 1934 Act, such number of copies of the U.S.
     Prospectus (as amended or supplemented) as such U.S. Underwriter
     may reasonably request. The U.S. Prospectus and any amendments or
     supplements thereto furnished to the U.S. Underwriters will be
     identical to the electronically transmitted copies thereof filed
     with the Commission pursuant to EDGAR, except to the extent
     permitted by Regulation S-T.

          (e) CONTINUED COMPLIANCE WITH SECURITIES LAWS. The Company
     will comply with the 1933 Act and the 1933 Act Regulations and
     the 1934 Act and the 1934 Act Regulations so as to permit the
     completion of the distribution of the Securities as contemplated
     in this Agreement, the International Purchase Agreement and in
     the Prospectuses. If at any time when a prospectus is required by
     the 1933 Act to be delivered in connection with sales of the
     Securities, any event shall occur or condition shall exist as a
     result of which it is necessary, in the opinion of counsel for
     the U.S. Underwriters or for the Company, to amend the
     Registration Statement or amend or supplement any Prospectus in
     order that the Prospectuses will not include any untrue
     statements of a material fact or omit to state a material fact
     necessary in order to make the statements therein not misleading
     in the light of the circumstances existing at the time any such
     Prospectus is delivered to a purchaser, or if it shall be
     necessary, in the opinion of such counsel, at any such time to
     amend the Registration Statement or amend or supplement any
     Prospectus in order to comply with the requirements of the 1933
     Act or the 1933 Act Regulations, the Company will (i) with
     respect to the U.S. Prospectus, promptly prepare and file with
     the Commission, subject to Section 3(b), such amendment or
     supplement as may be necessary to correct such statement or
     omission or to make the Registration Statement or the
     Prospectuses comply with such requirements, (ii) with respect to
     the International Prospectus, supplement such prospectus as may
     be necessary to correct such statement or omission, and (iii)
     furnish to the U.S. Underwriters such number of copies of each
     such amendment or supplement as the U.S. Underwriters may
     reasonably request.

          (f) BLUE SKY QUALIFICATIONS. The Company will use its
     reasonable best efforts in cooperation with the U.S.
     Underwriters, to qualify the Securities for offering and sale
     under the applicable securities laws of such states and other
     jurisdictions (domestic or foreign) as the Global Coordinator may
     designate and to maintain such qualifications in effect for a
     period of not less than one year from the later of the effective
     date of the Registration Statement and any Rule 462(b)
     Registration Statement; provided, however, that the Company shall
     not be obligated to file any general consent to service of
     process or to qualify as a foreign corporation or as a dealer in
     securities in any jurisdiction in which it is not so qualified or
     to subject itself to taxation in respect of doing business in any
     jurisdiction in which it is not otherwise so subject. In each
     jurisdiction in which the Securities have been so qualified, the
     Company will file such statements and reports as may be required
     by the laws of such jurisdiction to continue such qualification
     in effect for a period of not less than one year from the
     effective date of the Registration Statement and any Rule 462(b)
     Registration Statement.

          (g) RULE 158. The Company will timely file such reports
     pursuant to the 1934 Act as are necessary in order to make
     generally available to its securityholders as soon as practicable
     an earnings statement for the purposes of, and to provide the
     benefits contemplated by, the last paragraph of Section 11(a) of
     the 1933 Act.

          (h) LISTING. The Company will use its best efforts to effect
     the listing of the Securities on the New York Stock Exchange.

          (i) RESTRICTION ON SALE OF SECURITIES. During a period of 90
     days from the date of the Prospectuses, the Company will not,
     without the prior written consent of the Global Coordinator, (i)
     directly or indirectly, offer, pledge, sell, contract to sell,
     sell any option or contract to purchase, purchase any option or
     contract to sell, grant any option, right or warrant to purchase
     or otherwise transfer or dispose of any share of Common Stock or
     any securities convertible into or exercisable or exchangeable
     for Common Stock or file any registration statement under the
     1933 Act with respect to any of the foregoing or (ii) enter into
     any swap or any other agreement or any transaction that
     transfers, in whole or in part, directly or indirectly, the
     economic consequence of ownership of the Common Stock, whether
     any such swap or transaction described in clause (i) or (ii)
     above is to be settled by delivery of Common Stock or such other
     securities, in cash or otherwise. The foregoing sentence shall
     not apply to (A) the Securities to be sold hereunder or under the
     International Purchase Agreement, (B) any shares of Common Stock
     issued by the Company upon the exercise of an option or warrant
     or the conversion of a security outstanding on the date hereof
     and referred to in the Prospectuses, (C) any shares of Common
     Stock issued or options to purchase Common Stock granted pursuant
     to existing employee benefit plans of the Company referred to in
     the Prospectuses, or (D) any shares of Common Stock issued by the
     Company in connection with acquisitions by the Company; provided
     that, in the case of clause (D), it shall be a condition to such
     stock issuance that the third party receiving such shares
     executes a lock-up agreement on substantially the same terms as
     described above for a period expiring 90 days from the date of
     the Prospectus and there shall be no further transfer of such
     shares except in accordance with the provisions of such lock-up
     agreement.

          (j) REPORTING REQUIREMENTS. The Company, during the period
     when the U.S. Prospectus is required to be delivered under the
     1933 Act or the 1934 Act, will file all documents required to be
     filed with the Commission pursuant to the 1934 Act within the
     time periods required by the 1934 Act and the 1934 Act
     Regulations.

          (k) USE OF PROCEEDS. The Company will use the net proceeds
     received by it from the sale of the Securities in the manner
     specified in the Prospectuses under "Use of Proceeds".

     SECTION 4. Payment of Expenses. (a) EXPENSES. The Company will
pay all expenses incident to the performance of its obligations under
this Agreement, including (i) the preparation, printing and filing of
the Registration Statement (including financial statements and
exhibits) as originally filed and of each amendment thereto, (ii) the
preparation, copying and delivery to the Underwriters of this
Agreement, any Agreement Among Underwriters and such other documents
as may be required in connection with the offering, purchase, sale or
delivery of the Securities, (iii) the preparation, issuance and
delivery of the certificates for the Securities to the Underwriters,
including any stock or other transfer taxes and any stamp or other
duties payable upon the sale, issuance or delivery of the Securities
to the Underwriters and the transfer of the Securities between the
U.S. Underwriters and the International Managers, (iv) the fees and
disbursements of the Company's counsel, accountants and other
advisors, (v) the filing fees incident to any necessary filings under
state securities laws and the reasonable fees and disbursements of
counsel for the Underwriters in connection therewith and in connection
with the preparation of the Blue Sky Survey and any supplement
thereto, (vi) the printing and delivery to the Underwriters of copies
of each preliminary prospectus, any Term Sheets and of the
Prospectuses and any amendments or supplements thereto, (vii) the
preparation, printing and delivery to the Underwriters of copies of
the Blue Sky Survey and any supplement thereto, (viii) the fees and
expenses of any transfer agent or registrar for the Securities, and
(ix) the fees and expenses incurred in connection with the listing of
the Securities on the New York Stock Exchange.

     (b) TERMINATION OF AGREEMENT. If this Agreement is terminated by
the U.S. Representatives in accordance with the provisions of Section
5 or Section 9(a)(i) hereof, the Company shall reimburse the U.S.
Underwriters for all of their out-of-pocket expenses, including the
reasonable fees and disbursements of counsel for the U.S.
Underwriters.

     SECTION 5. Conditions of U.S. Underwriters' Obligations. The
obligations of the several U.S. Underwriters hereunder are subject to
the accuracy of the representations and warranties of the Company
contained in Section 1 hereof or in certificates of any officer of the
Company or any subsidiary of the Company delivered pursuant to the
provisions hereof, to the performance by the Company of its covenants
and other obligations hereunder, and to the following further
conditions:

          (a) EFFECTIVENESS OF REGISTRATION STATEMENT. The
     Registration Statement, including any Rule 462(b) Registration
     Statement, has become effective and at Closing Time no stop order
     suspending the effectiveness of the Registration Statement shall
     have been issued under the 1933 Act or proceedings therefor
     initiated or threatened by the Commission, and any request on the
     part of the Commission for additional information shall have been
     complied with to the reasonable satisfaction of counsel to the
     U.S. Underwriters. A prospectus containing the Rule 430A
     Information shall have been filed with the Commission in
     accordance with Rule 424(b) (or a post-effective amendment
     providing such information shall have been filed and declared
     effective in accordance with the requirements of Rule 430A).

          (b) OPINION OF COUNSEL FOR COMPANY. (i) At Closing Time, the
     U.S. Representatives shall have received the favorable opinion,
     dated as of Closing Time, of Fried, Frank, Harris, Shriver &
     Jacobson (a partnership including professional corporations),
     counsel for the Company, in form and substance satisfactory to
     counsel for the U.S. Underwriters, together with signed or
     reproduced copies of such letter for each of the other U.S.
     Underwriters to the effect set forth in Exhibit A-1 hereto and to
     such further effect as counsel to the U.S. Underwriters may
     reasonably request.

               (ii) At Closing Time, the U.S. Representatives shall
          have received the favorable opinion, dated as of Closing
          Time, of the General Counsel of the Company, in form and
          substance satisfactory to counsel for the U.S. Underwriters,
          together with signed or reproduced copies of such letter for
          each of the other U.S. Underwriters to the effect set forth
          in Exhibit A-2 hereto and to such further effect as counsel
          to the U.S. Underwriters may reasonably request.


          (c) OPINION OF COUNSEL FOR U.S. UNDERWRITERS. At Closing
     Time, the U.S. Representatives shall have received the favorable
     opinion, dated as of Closing Time, of Shearman & Sterling,
     counsel for the U.S. Underwriters, together with signed or
     reproduced copies of such letter for each of the other U.S.
     Underwriters. In giving such opinion such counsel may rely, as to
     all matters governed by the laws of jurisdictions other than the
     law of the State of New York, the federal law of the United
     States and the General Corporation law of the State of Delaware,
     upon the opinions of counsel satisfactory to the U.S.
     Representatives. Such counsel may also state that, insofar as
     such opinion involves factual matters, they have relied, to the
     extent they deem proper, upon certificates of officers of the
     Company and its subsidiaries and certificates of public
     officials.

          (d) OFFICERS' CERTIFICATE. At Closing Time, there shall not
     have been, since the date hereof or since the respective dates as
     of which information is given in the Prospectuses, any material
     adverse change in the condition, financial or otherwise, or in
     the earnings, business affairs or business prospects of the
     Company and its subsidiaries considered as one enterprise,
     whether or not arising in the ordinary course of business, and
     the U.S. Representatives shall have received a certificate of the
     President or a Vice President of the Company and of the chief
     financial or chief accounting officer of the Company, dated as of
     Closing Time, to the effect that (i) there has been no such
     material adverse change, (ii) the representations and warranties
     in Section 1(a) hereof are true and correct with the same force
     and effect as though expressly made at and as of Closing Time,
     (iii) the Company has complied with all agreements and satisfied
     all conditions on its part to be performed or satisfied at or
     prior to Closing Time, and (iv) no stop order suspending the
     effectiveness of the Registration Statement has been issued and
     no proceedings for that purpose have been instituted or are
     pending or are contemplated by the Commission.

          (e) ACCOUNTANTS' COMFORT LETTER. At the time of the
     execution of this Agreement, the U.S. Representatives shall have
     received from Deloitte & Touche LLP a letter dated such date, in
     form and substance satisfactory to the U.S. Representatives,
     together with signed or reproduced copies of such letter for each
     of the other U.S. Underwriters containing statements and
     information of the type ordinarily included in accountants'
     "comfort letters" to underwriters with respect to the financial
     statements and certain financial information contained in the
     Registration Statement and the Prospectuses.

          (f) BRING-DOWN COMFORT LETTER. At Closing Time, the U.S.
     Representatives shall have received from Deloitte & Touche LLP a
     letter, dated as of Closing Time, to the effect that they
     reaffirm the statements made in the letter furnished pursuant to
     subsection (e) of this Section, except that the specified date
     referred to shall be a date not more than three business days
     prior to Closing Time.

          (g) APPROVAL OF LISTING. At Closing Time, the Securities
     shall have been approved for listing on the New York Stock
     Exchange, subject only to official notice of issuance.

          (h) LOCK-UP AGREEMENTS. At the date of this Agreement, the
     U.S. Representatives shall have received an agreement
     substantially in the form of Exhibit B hereto signed by the
     persons listed on Schedule D hereto.

          (i) PURCHASE OF INITIAL INTERNATIONAL SECURITIES.
     Contemporaneously with the purchase by the U.S. Underwriters of
     the Initial U.S. Securities under this Agreement, the
     International Managers shall have purchased the Initial
     International Securities under the International Purchase
     Agreement.

          (j) CONDITIONS TO PURCHASE OF U.S. OPTION SECURITES. In the
     event that the U.S. Underwriters exercise their option provided
     in Section 2(b) hereof to purchase all or any portion of the U.S.
     Option Securities, the representations and warranties of the
     Company contained herein and the statements in any certificates
     furnished by the Company or any subsidiary of the Company
     hereunder shall be true and correct as of each Date of Delivery
     and, at the relevant Date of Delivery, the U.S. Representatives
     shall have received:

               (i) Officers' Certificate. A certificate, dated such
          Date of Delivery, of the President or a Vice President of
          the Company and of the chief financial or chief accounting
          officer of the Company confirming that the certificate
          delivered at Closing Time pursuant to Section 5(d) hereof
          remains true and correct as of such Date of Delivery.

               (ii) Opinion of Counsel for Company. (A) The favorable
          opinion of Fried, Frank, Harris, Shriver & Jacobson (a
          partnership including professional corporations), counsel
          for the Company, in form and substance satisfactory to
          counsel for the U.S. Underwriters, dated such Date of
          Delivery, relating to the U.S. Option Securities to be
          purchased on such Date of Delivery and otherwise to the same
          effect as the opinion required by Section 5(b)(i) hereof.

                         (B) The favorable opinion of the General
                    Counsel of the Company, in form and substance
                    satisfactory to counsel for the U.S. Underwriters,
                    dated such Date of Delivery, relating to the U.S.
                    Option Securities to be purchased on such Date of
                    Delivery and otherwise to the same effect as the
                    opinion required by Section 5(b)(ii) hereof.

               (iii) Opinion of Counsel for U.S. Underwriters. The
          favorable opinion of Shearman & Sterling, counsel for the
          U.S. Underwriters, dated such Date of Delivery, relating to
          the U.S. Option Securities to be purchased on such Date of
          Delivery and otherwise to the same effect as the opinion
          required by Section 5(c) hereof.

               (iv) Bring-down Comfort Letter. A letter from Deloitte
          & Touche LLP, in form and substance satisfactory to the U.S.
          Representatives and dated such Date of Delivery,
          substantially in the same form and substance as the letter
          furnished to the U.S. Representatives pursuant to Section
          5(f) hereof, except that the "specified date" in the letter
          furnished pursuant to this paragraph shall be a date not
          more than five days prior to such Date of Delivery.

          (k) ADDITIONAL DOCUMENTS. At Closing Time and at each Date
     of Delivery, counsel for the U.S. Underwriters shall have been
     furnished with such documents and opinions as they may require
     for the purpose of enabling them to pass upon the issuance and
     sale of the Securities as herein contemplated, or in order to
     evidence the accuracy of any of the representations or
     warranties, or the fulfillment of any of the conditions, herein
     contained; and all proceedings taken by the Company in connection
     with the issuance and sale of the Securities as herein
     contemplated shall be satisfactory in form and substance to the
     U.S. Representatives and counsel for the U.S. Underwriters.

          (l) TERMINATION OF AGREEMENT. If any condition specified in
     this Section shall not have been fulfilled when and as required
     to be fulfilled, this Agreement, or, in the case of any condition
     to the purchase of U.S. Option Securities on a Date of Delivery
     which is after the Closing Time, the obligations of the several
     U.S. Underwriters to purchase the relevant Option Securities, may
     be terminated by the U.S. Representatives by notice to the
     Company at any time at or prior to Closing Time or such Date of
     Delivery, as the case may be, and such termination shall be
     without liability of any party to any other party except as
     provided in Section 4 and except that Sections 1, 6, 7 and 8
     shall survive any such termination and remain in full force and
     effect.

     SECTION 6. Indemnification.

     (a) INDEMNIFICATION OF U.S. UNDERWRITERS. The Company agrees to
indemnify and hold harmless each U.S. Underwriter and each person, if
any, who controls any U.S. Underwriter within the meaning of Section
15 of the 1933 Act or Section 20 of the 1934 Act as follows:

          (i) against any and all loss, liability, claim, damage and
     expense whatsoever, as incurred, arising out of any untrue
     statement or alleged untrue statement of a material fact
     contained in the Registration Statement (or any amendment
     thereto), including the Rule 430A Information or the omission or
     alleged omission therefrom of a material fact required to be
     stated therein or necessary to make the statements therein not
     misleading or arising out of any untrue statement or alleged
     untrue statement of a material fact included in any preliminary
     prospectus or the Prospectuses (or any amendment or supplement
     thereto), or the omission or alleged omission therefrom of a
     material fact necessary in order to make the statements therein,
     in the light of the circumstances under which they were made, not
     misleading;

          (ii) against any and all loss, liability, claim, damage and
     expense whatsoever, as incurred, to the extent of the aggregate
     amount paid in settlement of any litigation, or any investigation
     or proceeding by any governmental agency or body, commenced or
     threatened, or of any claim whatsoever based upon any such untrue
     statement or omission, or any such alleged untrue statement or
     omission; provided that (subject to Section 6(d) below) any such
     settlement is effected with the written consent of the Company;
     and

          (iii) against any and all expense whatsoever, as incurred
     (including the fees and disbursements of counsel chosen by
     Merrill Lynch), reasonably incurred in investigating, preparing
     or defending against any litigation, or any investigation or
     proceeding by any governmental agency or body, commenced or
     threatened, or any claim whatsoever based upon any such untrue
     statement or omission, or any such alleged untrue statement or
     omission, to the extent that any such expense is not paid under
     (i) or (ii) above;

provided, however, that this indemnity agreement shall not apply to
any loss, liability, claim, damage or expense to the extent arising
out of any untrue statement or omission or alleged untrue statement or
omission made in reliance upon and in conformity with written
information furnished to the Company by any U.S. Underwriter through
the U.S. Representatives expressly for use in the Registration
Statement (or any amendment thereto), including the Rule 430A
Information or any preliminary U.S. prospectus or the U.S. Prospectus
(or any amendment or supplement thereto); provided, further, that the
Company will not be liable to any U.S. Underwriter or any person
controlling such U.S. Underwriter with respect to any such untrue
statement or alleged untrue statement or omission or alleged omission
made in any preliminary prospectus to the extent that the Company
shall sustain the burden of proving that any such loss, liability,
claim, damage or expense resulted from the fact that such U.S.
Underwriter, in contravention of a requirement of this Agreement or
applicable law, sold securities to a person to whom such U.S.
Underwriter failed to send or give, at or prior to the written
confirmation of the sale of such Securities, a copy of the U.S.
Prospectus (as amended or supplemented) if (i) the Company has
previously furnished copies thereof (sufficiently in advance of the
Closing Date to allow for distribution of the U.S. Prospectus in a
timely manner) to the U.S. Underwriter and the loss, liability, claim,
damage or expense of such U.S. Underwriter resulted from an untrue
statement or omission or alleged untrue statement or omission of a
material fact contained in or omitted from such preliminary U.S.
prospectus which was corrected in the U.S. Prospectus and (ii) the
giving or sending of such U.S. Prospectus by the Closing Date to the
party or parties asserting such loss, liability, claim or damage or
expense would have constituted the sole defense to the claim asserted
by such person.

     (b) INDEMNIFICATION OF COMPANY, DIRECTORS AND OFFICERS. Each U.S.
Underwriter severally agrees to indemnify and hold harmless the
Company, its directors, each of its officers who signed the
Registration Statement, and each person, if any, who controls the
Company within the meaning of Section 15 of the 1933 Act or Section 20
of the 1934 Act against any and all loss, liability, claim, damage and
expense described in the indemnity contained in subsection (a) of this
Section, as incurred, but only with respect to untrue statements or
omissions, or alleged untrue statements or omissions, made in the
Registration Statement (or any amendment thereto), including the Rule
430A Information or any preliminary U.S. prospectus or the U.S.
Prospectus (or any amendment or supplement thereto) in reliance upon
and in conformity with written information furnished to the Company by
such U.S. Underwriter through the U.S. Representatives expressly for
use in the Registration Statement (or any amendment thereto) or such
preliminary U.S. prospectus or the U.S. Prospectus (or any amendment
or supplement thereto).

     (c) ACTIONS AGAINST PARTIES; NOTIFICATION. Each indemnified party
shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of
which indemnity may be sought hereunder, but failure to so notify an
indemnifying party shall not relieve such indemnifying party from any
liability hereunder to the extent it is not materially prejudiced as a
result thereof and in any event shall not relieve it from any
liability which it may have otherwise than on account of this
indemnity agreement. In the case of parties indemnified pursuant to
Section 6(a) above, counsel to the indemnified parties shall be
selected by Merrill Lynch, and, in the case of parties indemnified
pursuant to Section 6(b) above, counsel to the indemnified parties
shall be selected by the Company. An indemnifying party may
participate at its own expense in the defense of any such action;
provided, however, that counsel to the indemnifying party shall not
(except with the consent of the indemnified party) also be counsel to
the indemnified party. In no event shall the indemnifying parties be
liable for fees and expenses of more than one counsel (in addition to
any local counsel) separate from their own counsel for all indemnified
parties in connection with any one action or separate but similar or
related actions in the same jurisdiction arising out of the same
general allegations or circumstances. No indemnifying party shall,
without the prior written consent of the indemnified parties, settle
or compromise or consent to the entry of any judgment with respect to
any litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or any claim whatsoever in
respect of which indemnification or contribution could be sought under
this Section 6 or Section 7 hereof (whether or not the indemnified
parties are actual or potential parties thereto), unless such
settlement, compromise or consent (i) includes an unconditional
release of each indemnified party from all liability arising out of
such litigation, investigation, proceeding or claim and (ii) does not
include a statement as to or an admission of fault, culpability or a
failure to act by or on behalf of any indemnified party.

     (d) SETTLEMENT WITHOUT CONSENT IF FAILURE TO REIMBURSE. If at any
time an indemnified party shall have requested an indemnifying party
to reimburse the indemnified party for fees and expenses of counsel,
such indemnifying party agrees that it shall be liable for any
settlement of the nature contemplated by Section 6(a)(ii) effected
without its written consent if (i) such settlement is entered into
more than 45 days after receipt by such indemnifying party of the
aforesaid request, (ii) such indemnifying party shall have received
notice of the terms of such settlement at least 30 days prior to such
settlement being entered into and (iii) such indemnifying party shall
not have reimbursed such indemnified party in accordance with such
request prior to the date of such settlement.

     SECTION 7. Contribution. If the indemnification provided for in
Section 6 hereof is for any reason unavailable to or insufficient to
hold harmless an indemnified party in respect of any losses,
liabilities, claims, damages or expenses referred to therein, then
each indemnifying party shall contribute to the aggregate amount of
such losses, liabilities, claims, damages and expenses incurred by
such indemnified party, as incurred, (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company
on the one hand and the U.S. Underwriters on the other hand from the
offering of the Securities pursuant to this Agreement or (ii) if the
allocation provided by clause (i) is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the relative fault
of the Company on the one hand and of the U.S. Underwriters on the
other hand in connection with the statements or omissions which
resulted in such losses, liabilities, claims, damages or expenses, as
well as any other relevant equitable considerations.

     The relative benefits received by the Company on the one hand and
the U.S. Underwriters on the other hand in connection with the
offering of the U.S. Securities pursuant to this Agreement shall be
deemed to be in the same respective proportions as the total net
proceeds from the offering of the U.S. Securities pursuant to this
Agreement (before deducting expenses) received by the Company and the
total underwriting discount received by the U.S. Underwriters, in each
case as set forth on the cover of the U.S. Prospectus bear to the
aggregate initial public offering price of the U.S. Securities as set
forth on such cover.

     The relative fault of the Company on the one hand and the U.S.
Underwriters on the other hand shall be determined by reference to,
among other things, whether any such untrue or alleged untrue
statement of a material fact or omission or alleged omission to state
a material fact relates to information supplied by the Company or by
the U.S. Underwriters and the parties' relative intent, knowledge,
access to information and opportunity to correct or prevent such
statement or omission.

     The Company and the U.S. Underwriters agree that it would not be
just and equitable if contribution pursuant to this Section were
determined by pro rata allocation (even if the U.S. Underwriters were
treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations
referred to above in this Section. The aggregate amount of losses,
liabilities, claims, damages and expenses incurred by an indemnified
party and referred to above in this Section shall be deemed to include
any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation,
or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever based upon any such
untrue or alleged untrue statement or omission or alleged omission.

     Notwithstanding the provisions of this Section, no U.S.
Underwriter shall be required to contribute any amount in excess of
the amount by which the total price at which the U.S. Securities
underwritten by it and distributed to the public were offered to the
public exceeds the amount of any damages which such U.S. Underwriter
has otherwise been required to pay by reason of any such untrue or
alleged untrue statement or omission or alleged omission.

     No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 1933 Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation.

     For purposes of this Section, each person, if any, who controls a
U.S. Underwriter within the meaning of Section 15 of the 1933 Act or
Section 20 of the 1934 Act shall have the same rights to contribution
as such U.S. Underwriter, and each director of the Company, each
officer of the Company who signed the Registration Statement, and each
person, if any, who controls the Company within the meaning of Section
15 of the 1933 Act or Section 20 of the 1934 Act shall have the same
rights to contribution as the Company. The U.S. Underwriters'
respective obligations to contribute pursuant to this Section are
several in proportion to the number of Initial U.S. Securities set
forth opposite their respective names in Schedule A hereto and not
joint.

     SECTION 8. Representations, Warranties and Agreements to Survive
Delivery. All representations, warranties and agreements contained in
this Agreement or in certificates of officers of the Company or any of
its subsidiaries submitted pursuant hereto shall remain operative and
in full force and effect, regardless of any investigation made by or
on behalf of any U.S. Underwriter or controlling person, or by or on
behalf of the Company, and shall survive delivery of the Securities to
the U.S. Underwriters.

     SECTION 9. Termination of Agreement.
                ------------------------

     (a) TERMINATION; GENERAL. The U.S. Representatives may terminate
this Agreement, by notice to the Company, at any time at or prior to
Closing Time (i) if there has been, since the time of execution of
this Agreement or since the respective dates as of which information
is given in the U.S. Prospectus, any material adverse change in the
condition, financial or otherwise, or in the earnings, business
affairs or business prospects of the Company and its subsidiaries
considered as one enterprise, whether or not arising in the ordinary
course of business, or (ii) if there has occurred any material adverse
change in the financial markets in the United States or the
international financial markets, any outbreak of hostilities or
escalation thereof or other calamity or crisis or any change or
development involving a prospective change in national or
international political, financial or economic conditions, in each
case the effect of which is such as to make it, in the judgment of the
U.S. Representatives, impracticable to market the Securities or to
enforce contracts for the sale of the Securities, or (iii) if trading
in any securities of the Company has been suspended or materially
limited by the Commission or the New York Stock Exchange, or if
trading generally on the American Stock Exchange or the New York Stock
Exchange or in the Nasdaq National Market has been suspended or
materially limited, or minimum or maximum prices for trading have been
fixed, or maximum ranges for prices have been required, by any of said
exchanges or by such system or by order of the Commission, the
National Association of Securities Dealers, Inc. or any other
governmental authority, or (iv) if a banking moratorium has been
declared by either Federal or New York authorities.

     (b) LIABILITIES. If this Agreement is terminated pursuant to this
Section, such termination shall be without liability of any party to
any other party except as provided in Section 4 hereof, and provided
further that Sections 1, 6, 7 and 8 shall survive such termination and
remain in full force and effect.

     SECTION 10. Default by One or More of the U.S. Underwriters. If
one or more of the U.S. Underwriters shall fail at Closing Time or a
Date of Delivery to purchase the Securities which it or they are
obligated to purchase under this Agreement (the "Defaulted
Securities"), the U.S. Representatives shall have the right, within 24
hours thereafter, to make arrangements for one or more of the
non-defaulting U.S. Underwriters, or any other underwriters, to
purchase all, but not less than all, of the Defaulted Securities in
such amounts as may be agreed upon and upon the terms herein set
forth; if, however, the U.S. Representatives shall not have completed
such arrangements within such 24-hour period, then:

          (a) if the number of Defaulted Securities does not exceed
     10% of the number of U.S. Securities to be purchased on such
     date, the non-defaulting U.S. Underwriters shall be obligated,
     each severally and not jointly, to purchase the full amount
     thereof in the proportions that their respective underwriting
     obligations hereunder bear to the underwriting obligations of all
     non-defaulting U.S. Underwriters, or

          (b) if the number of Defaulted Securities exceeds 10% of the
     number of U.S. Securities to be purchased on such date, this
     Agreement or, with respect to any Date of Delivery which occurs
     after Closing Time, the obligation of the U.S. Underwriters to
     purchase and of the Company to sell the Option Securities to be
     purchased and sold on such Date of Delivery shall terminate
     without liability on the part of any non-defaulting U.S.
     Underwriter.

     No action taken pursuant to this Section shall relieve any
defaulting U.S. Underwriter from liability in respect of its default.

     In the event of any such default which does not result in a
termination of this Agreement or, in the case of a Date of Delivery
which is after Closing Time, which does not result in a termination of
the obligation of the U.S. Underwriters to purchase and the Company to
sell the relevant U.S. Option Securities, as the case may be, either
the U.S. Representative(s) or the Company shall have the right to
postpone Closing Time or the relevant Date of Delivery, as the case
may be, for a period not exceeding seven days in order to effect any
required changes in the Registration Statement or Prospectuses or in
any other documents or arrangements. As used herein, the term "U.S.
Underwriter" includes any person substituted for a U.S. Underwriter
under this Section.

     SECTION 11. Notices. All notices and other communications
hereunder shall be in writing and shall be deemed to have been duly
given if mailed or transmitted by any standard form of
telecommunication. Notices to the U.S. Underwriters shall be directed
to the U.S. Representatives at North Tower, World Financial Center,
New York, New York 10281, attention of Scott E. Haggard; and notices
to the Company shall be directed to it at 15501 North Dial Boulevard,
Scottsdale, Arizona 85260-1619, attention of Jane E. Owens, Senior
Vice President and General Counsel.

     SECTION 12. Parties. This Agreement shall inure to the benefit of
and be binding upon the U.S. Underwriters and the Company and their
respective successors. Nothing expressed or mentioned in this
Agreement is intended or shall be construed to give any person, firm
or corporation, other than the U.S. Underwriters and the Company and
their respective successors and the controlling persons and officers
and directors referred to in Sections 6 and 7 and their heirs and
legal representatives, any legal or equitable right, remedy or claim
under or in respect of this Agreement or any provision herein
contained. This Agreement and all conditions and provisions hereof are
intended to be for the sole and exclusive benefit of the U.S.
Underwriters and the Company and their respective successors, and said
controlling persons and officers and directors and their heirs and
legal representatives, and for the benefit of no other person, firm or
corporation. No purchaser of Securities from any U.S. Underwriter
shall be deemed to be a successor by reason merely of such purchase.

     SECTION 13. GOVERNING LAW AND TIME. THIS AGREEMENT SHALL BE
GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.

     SECTION 14. Effect of Headings. The Article and Section headings
herein and the Table of Contents are for convenience only and shall
not affect the construction hereof.




     If the foregoing is in accordance with your understanding of our
agreement, please sign and return to the Company a counterpart hereof,
whereupon this instrument, along with all counterparts, will become a
binding agreement between the U.S. Underwriters and the Company in
accordance with its terms.

                                   Very truly yours,

                                   THE DIAL CORPORATION


                                   By: /s/ Malcolm Jozoff
                                       ----------------------------------------
                                       Malcolm Jozoff
                                       Chairman of the Board of Directors,
                                       President  and  Chief  Executive Officer

CONFIRMED AND ACCEPTED,
      AS OF  THE  DATE  FIRST  ABOVE WRITTEN:


MERRILL LYNCH & CO.
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
J.P.MORGAN SECURITIES INC.
NATIONSBANC MONTGOMERY SECURITIES, INC.
PAINEWEBBER INCORPORATED
PRUDENTIAL SECURITIES INCORPORATED
SMITH BARNEY INC.



By:  MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED



By:  /s/ Scott E. Haggard
     ---------------------------
     Authorized Signatory



For  themselves  and as U.S.  Representatives  of the other U.S.  Underwriters
named in Schedule A hereto.




                              SCHEDULE A


      Name of U.S. Underwriter                                     Number of
      ------------------------                                    Initial U.S.
                                                                  Securities
                                                                  ----------

Merrill Lynch, Pierce, Fenner & Smith Incorporated .........           597,626
J.P. Morgan Securities Inc. ................................           597,625
NationsBanc Montgomery Securities, Inc. ....................           597,625
PaineWebber Incorporated ...................................           597,625
Prudential Securities Incorporated .........................           597,625
Smith Barney Inc. ..........................................           597,625
Bear, Stearns & Co. Inc.....................................           150,000
Credit Suisse First Boston Corporation......................           150,000
Donaldson, Lufkin & Jenrette Securities Corporation.........           150,000
A.G. Edwards & Sons, Inc....................................           150,000
Goldman, Sachs & Co.........................................           150,000
Lehman Brothers Inc.........................................           150,000
Edward D. Jones & Co., L.P..................................            70,000
RBC Dominion Securities Corporation.........................            70,000
Wheat, First Securities, Inc................................            70,000
                                                               ---------------

Total.......................................................         4,695,751
                                                               ===============




                              SCHEDULE B

                         THE DIAL CORPORATION

                   4,695,751 Shares of Common Stock
                      (Par Value $0.01 Per Share)



     1. The initial public offering price per share for the
Securities, determined as provided in said Section 2, shall be
$18.3125.

     2. The purchase price per share for the U.S. Securities to be
paid by the several U.S. Underwriters shall be $17.3925, being an
amount equal to the initial public offering price set forth above less
$0.92 per share; provided that the purchase price per share for any
U.S. Option Securities purchased upon the exercise of the
over-allotment option described in Section 2(b) shall be reduced by an
amount per share equal to any dividends or distributions declared by
the Company and payable on the Initial U.S. Securities but not payable
on the U.S. Option Securities.




                              SCHEDULE C

                             SUBSIDIARIES



Andora S.A. (Mexico)
ARMOUR INTERNATIONAL COMPANY (Arizona)
      AIC Foreign Sales Corporation (Virgin Islands)
      The Dial Corporation (Panama), S.A. (Panama)
Dial Consumer Products (UK) Limited (United Kingdom)
      Armour International Limited (United Kingdom)
The Dial Corporation (Hong Kong) Limited
The Dial Corporation Mexico, S.A., de C.V. (Mexico)
The Dial Corporation (Puerto Rico), Inc. (Arizona)
Ft. Madison Dial, Inc. (Iowa)
ISC International Ltd. (British Virgin Islands)
      ISC Incodisa Soap & Cosmetics (U.K.) Limited (United Kingdom)
      Industrias Corporativas Diversificadas, S.A. (Guatemala)
      ISC Incodisa Soap & Cosmetics - Nyon (Switzerland)
      I.S.C. Internacional S.A. (Guatemala)
Limpioquim San Juan S.A. (Argentina)
Nuevo Federal S.A. (Argentina)
Philidial International, Inc. (Delaware)
Purex de Panama, S.A. (Panama)
Sulfargen S.A. (Argentina)
Dial Receivables Corporation (Delaware)




                              SCHEDULE D

Malcolm Jozoff
Pataricia I. Bowman
Daniel J. King
Scott McHenry
Jane E. Owens
Susan J. Riley
Lowell L. Robertson
Mark R. Shook
Bernhard J. Welle
Joy A. Amundson
Herbert M. Baum
Joe T. Ford
Thomas L. Gossage
Donald E. Guinn
Michael T. Riordan
Dennis C. Stanfill
Barbara S. Thomas
A. Thomas Young



 [Form of Opinion of Company's Counsel to be Delivered Pursuant to Section
                               5(b)(i)]
                                                           Exhibit A-1

Merrill Lynch & Co.
Merrill Lynch, Pierce, Fenner & Smith
            Incorporated
J.P. Morgan Securities Inc.
NationsBanc Montgomery Securities, Inc.
PaineWebber Incorporated
Prudential Securities Incorporated
Smith Barney Inc.
c/o Merrill Lynch & Co.
    Merrill Lynch, Pierce, Fenner & Smith
                Incorporated
North Tower
World Financial Center
New York, New York  10281

Merrill Lynch International
J.P. Morgan Securities Ltd.
NationsBanc Montgomery Securities, Inc.
PaineWebber International
Prudential-Bache Securities (U.K.) Inc.
Smith Barney Inc.
c/o Merrill Lynch International
Ropemaker Place
25 Ropemaker Street
London, England EC2Y 9LY

Ladies and Gentlemen:

           We are acting as special counsel to The Dial Corporation, a
Delaware corporation (the "Company"), in connection with the
underwritten public offerings of 5,460,751 shares of the Company's
Common Stock (the "Securities"), pursuant to (i) a Purchase Agreement
(the "U.S. Purchase Agreement"), dated as of November 10, 1997, among
the Company and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner &
Smith Incorporated, J.P. Morgan Securities Inc., NationsBanc
Montgomery Securities, Inc., PaineWebber Incorporated, Prudential
Securities Incorporated and Smith Barney Inc., as representatives of
the U.S. Underwriters, and (ii) an International Purchase Agreement
(the "International Purchase Agreement," and together with the U.S.
Purchase Agreement, the "Purchase Agreements") among the Company and
Merrill Lynch International, J.P. Morgan Securities Ltd., NationsBanc
Montgomery Securities, Inc., PaineWebber International,
Prudential-Bache Securities (U.K) Inc. and Smith Barney Inc., as
representatives of the International Managers. This opinion is being
delivered pursuant to Section 5(b) of each of the Purchase Agreements
and simultaneously with the payment by the Underwriters to the Company
for the Securities. Except as provided herein, all capitalized terms
used herein which are defined in the Purchase Agreements have the
respective meanings specified therein. With your permission, all
assumptions and statements of reliance herein have been made without
any independent investigation or verification on our part except to
the extent otherwise expressly stated, and we express no opinion with
respect to the subject matter or accuracy of such assumptions or items
relied upon.

           In connection with this opinion, we have (i) investigated
such questions of law, (ii) examined originals or certified, conformed
or reproduction copies of such agreements, instruments, documents and
records of the Company such certificates of public officials and such
other documents, and (iii) reviewed such information from officers and
representatives of the Company as we have deemed necessary or
appropriate for the purposes of this opinion.

           In all such examinations, we have assumed the legal
capacity of all natural persons executing documents, the genuineness
of all signatures, the authenticity of all original or certified
copies and the conformity to original or certified documents of all
copies submitted to us as conformed or reproduction copies. As to
various questions of fact relevant to the opinions expressed herein,
we have relied upon, and assume the accuracy of, representations and
warranties contained in the Purchase Agreements and certificates and
oral or written statements and other information of or from public
officials and officers and representatives of the Company and others,
and assume compliance on the part of all parties to the Purchase
Agreements with their covenants and agreements contained therein. With
respect to the opinion expressed in paragraph 3 below, we have relied
solely upon certificates of public officials from the jurisdictions
identified in such opinion, copies of which have been provided to you.
With respect to the opinion expressed in paragraph 8 below regarding
the effectiveness of the Registration Statement and the absence of any
stop orders or proceedings for that purpose, we are relying solely
upon the oral advice of the staff of the Securities and Exchange
Commission (the "Commission").

           Based upon the foregoing, and subject to the limitations,
qualifications and assumptions set forth herein, we are of the opinion
that:

1.   The Company has been duly incorporated and is validly existing as
     a corporation in good standing under the laws of the State of
     Delaware.

2.   The Company has the corporate power and authority to own, lease
     and operate its properties and to conduct its business as
     described in the Registration Statement and to enter into and
     perform its obligations under the Purchase Agreements.

3.   The Company is duly qualified as a foreign corporation to
     transact business and is in good standing under the laws of the
     States of Arizona, Iowa, Missouri, Pennsylvania and California.

4.   All of the authorized, issued and outstanding Common Stock of the
     Company is as set forth in the Prospectuses in the column
     entitled "Actual" under the caption "Capitalization"; and none of
     the outstanding shares of capital stock of the Company was issued
     in violation of the preemptive or other similar rights of any
     securityholder of the Company arising by operation of law, under
     the charter and by-laws of the Company or under any agreement,
     which has been filed as an exhibit to the Registration Statement
     (the "Applicable Contracts").

5.   All of the authorized, issued and outstanding shares of Common
     Stock of the Company are duly authorized, validly issued, fully
     paid and non-assessable. The Securities to be purchased by the
     Underwriters from the Company have been duly authorized for
     issuance and sale to the Underwriters pursuant to the Purchase
     Agreements and, when issued and delivered by the Company pursuant
     to the Purchase Agreements against payment of the consideration
     set forth in the Purchase Agreements, will be duly authorized,
     validly issued, fully paid and non-assessable and no holder of
     the Securities is or will be subject to personal liability under
     the Delaware General Corporation Law by reason of being such a
     holder.

6.   The issuance and sale of the Securities by the Company is not
     subject to preemptive or other similar rights arising by
     operation of law, under the Delaware General Corporation Law,
     under the charter or by-laws of the Company or, to the best of
     our knowledge, under any contract with any securityholder.

7.   Each of the Purchase Agreements has been duly authorized,
     executed and delivered by the Company.

8.   The Registration Statement[, including any Rule 462(b)
     Registration Statement,] has been declared effective under the
     1933 Act; any required filing of the Prospectuses pursuant to
     Rule 424(b) has been made in the manner and within the time
     period required by Rule 424(b); and, to the best of our
     knowledge, no stop order suspending the effectiveness of the
     Registration Statement [or any Rule 462(b) Registration
     Statement] has been issued under the 1933 Act and no proceedings
     for that purpose have been instituted or are pending or
     threatened by the Commission.

9.   The Registration Statement[, including any Rule 462(b)
     Registration Statement, as applicable,] the Prospectuses, and
     each amendment or supplement to the Registration Statement and
     the Prospectuses, as of their respective effective or issue dates
     (other than the financial statements, related notes, supporting
     schedules and other financial data included therein or omitted
     therefrom, as to which we express no opinion) complied as to form
     in all material respects with the requirements of the 1933 Act or
     the 1933 Act Regulations and the rules thereunder.

10.  The documents incorporated by reference in the Prospectuses
     (other than the financial statements, related notes, supporting
     schedules and other financial data included therein or omitted
     therefrom, as to which we express no opinion), when they became
     effective or were filed with the Commission, as the case may be,
     complied as to form in all material respects with the
     requirements of the 1933 Act or the 1934 Act, as applicable, and
     the rules and regulations of the Commissioner thereunder.

11.  The form of certificate used to evidence the Common Stock
     complies in all material respects with all applicable statutory
     requirements, with any applicable requirements of the charter and
     by-laws of the Company and the requirements of the New York Stock
     Exchange.

12.  The information in the Prospectuses under "Description of Capital
     Stock," and "Certain United States Federal Tax Considerations for
     Non-United States Holders" and in the Registration Statement
     under Item 15, to the extent that it constitutes matters of law,
     summaries of legal matters, the Company's charter and by-laws or
     legal conclusions, has been reviewed by us and fairly presents in
     all material respects, such matters, summaries or conclusions.

13.  No filing with, or authorization approval, consent, license,
     order, registration, qualification or decree of, any New York,
     Delaware or federal court or governmental authority or New York,
     Delaware or federal agency, is necessary or required in
     connection with the due authorization, execution and delivery of
     the Purchase Agreements or for the offering, issuance, sale or
     delivery of the Securities (other than under the 1933 Act and the
     1933 Act Regulations, which have been obtained, or as may be
     required under the securities or blue sky laws of the various
     states).

14.  The execution, delivery and performance of the Purchase
     Agreements and the consummation of the transactions contemplated
     in the Purchase Agreements (including the issuance and sale of
     the Securities and the use of the proceeds from the sale of the
     Securities as described in the Prospectuses under the caption
     "Use Of Proceeds") and compliance by the Company with its
     obligations under the Purchase Agreements do not and will not,
     whether with or without the giving of notice or lapse of time or
     both, violate or constitute a breach of, or default or Repayment
     Event (as defined in Section 1(a)(xi) of the Purchase Agreements)
     under, or result in the creation or imposition of any lien,
     charge or encumbrance upon any property or assets of the Company
     or any subsidiary pursuant to, any Applicable Contract, nor will
     such action result in any violation of the provisions of the
     charter or by-laws of the Company, or any applicable federal, New
     York or Delaware law, statute, rule, regulation, or any judgment,
     order, writ or decree, known to us, of any government, government
     instrumentality or court of the United States, or New York or
     Delaware having jurisdiction over the Company or any subsidiary
     or any of their respective properties, assets or operations,
     which in any such case would result in a Material Adverse Effect;
     provided, however, that we express no opinion with respect to any
     violation, breach or default or Repayment Event, as applicable,
     not ascertainable from the face of any agreement, instrument,
     judgment, decree or order referred to above, or arising under or
     based upon any cross-default provision insofar as any such
     violation relates to a default under an agreement or instrument
     that is not an Applicable Contract or such violation arises under
     or is based upon any covenant of a financial or numerical nature
     or which requires arithmetic computation.

15.  The Company is not an "investment company," as such term is
     defined in the Investment Company Act of 1940, as amended.

           In the course of the preparation by the Company of the
Registration Statement and the Prospectuses (other than the documents
incorporated by reference therein), we attended conferences with
certain of the officers of, and the independent public accountants
for, the Company, at which the Registration Statement and the
Prospectuses were discussed. Between the date of effectiveness of the
Registration Statement and the time of delivery of this opinion, we
attended additional conferences with certain of the officers of, and
the independent public accountants for, the Company, at which the
contents of the Prospectuses were discussed to a limited extent. Given
the limitations inherent in the independent verification of factual
matters and the character of determinations involved in the
registration process, we are not passing upon and do not assume any
responsibility for the accuracy, completenesss or fairness of the
statements contained in the Registration Statement and the
Prospectuses (including the documents incorporated by reference
therein), other than as set forth in paragraph 12 above. Subject to
the foregoing and on the basis of the information we gained in the
performance of the services referred to above, including information
obtained from officers and other representatives of, and the
independent accountants for, the Company, nothing has come to our
attention that causes us to believe that, as of the time it became
effective, the Registration Statement contained an untrue statement of
a material fact or omitted to state a material fact required to be
stated therein or necessary to make the statements therein not
misleading, or that the Prospectuses as of their dates contained any
untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they
were made, not misleading. Also, subject to the foregoing, nothing has
come to our attention in the course of proceedings described in the
second sentence of this paragraph that causes us to believe that the
Prospectuses on the date and time of delivery of this letter contain
an untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. We express
no view or belief, however, with respect to the financial statements,
related notes and schedules thereto and other financial data included
or incorporated by reference in or omitted from the Registration
Statement or the Prospectuses.

           The opinions set forth above are subject to the following
additional qualifications:

           (A) Our opinions are subject to (i) applicable bankruptcy,
insolvency, moratorium, fraudulent transfer, fraudulent conveyance,
and other similar laws affecting creditors' rights and remedies
generally, and (ii) general principles of equity (including, without
limitation, standards of materiality, good faith, fair dealing and
reasonableness, equitable defenses and limits as the availability of
equitable remedies), whether such principles are considered in a
proceeding at law or equity.

           (B) Our opinions are subject to the effect of, and we
express no opinion with respect to, the application of or compliance
with, state securities or blue sky laws.

           The opinions expressed herein are limited to the federal
laws of the United States of America, the General Corporation Law of
the State of Delaware and the laws of the State of New York, as
currently in effect. We assume no obligations to supplement this
letter if any applicable laws change after the date hereof or if we
become aware of any facts that might change the opinions expressed
herein after the date hereof.

           The opinions expressed herein are solely for your benefit
and may not be relied upon in any manner or for any purpose by any
other person and may not be quoted in whole or in part without our
prior written consent.

                                         Very truly yours,

                             FRIED, FRANK, HARRIS, SHRIVER & JACOBSON



                             By:______________________________________
                                         Stuart H. Gelfond




 [Form of Opinion of Company's In-House Counsel to be Delivered Pursuant to
                           Section 5(b)(ii)]
                                                           Exhibit A-2

                                                     November __, 1997


Merrill Lynch & Co.
Merrill Lynch, Pierce, Fenner & Smith
            Incorporated
J.P. Morgan Securities Inc.
NationsBanc Montgomery Securities, Inc.
PaineWebber Incorporated
Prudential Securities Incorporated
Smith Barney Inc.
c/o Merrill Lynch & Co.
    Merrill Lynch, Pierce, Fenner & Smith
                Incorporated
North Tower
World Financial Center
New York, New York  10281


Merrill Lynch International
J.P. Morgan Securities Ltd.
NationsBanc Montgomery Securities, Inc.
PaineWebber International
Prudential-Bache Securities (U.K.) Inc.
Smith Barney Inc.
c/o Merrill Lynch International
Ropemaker Place
25 Ropemaker Street
London, England EC2Y 9LY

Ladies and Gentlemen:

           I am acting as in-house counsel to The Dial Corporation, a
Delaware corporation (the "Company"), in connection with the
underwritten public offerings of 5,460,751 shares of the Company's
Common Stock (the "Securities"), pursuant to (i) a Purchase Agreement
(the "U.S. Purchase Agreement"), dated as of November 10, 1997, among
the Company and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner &
Smith Incorporated, J.P. Morgan Securities Inc., NationsBanc
Montgomery Securities, Inc., PaineWebber Incorporated, Prudential
Securities Incorporated and Smith Barney Inc., as representatives of
the U.S. Underwriters, and (ii) an International Purchase Agreement
(the "International Purchase Agreement," and together with the U.S.
Purchase Agreement, the "Purchase Agreements") among the Company and
Merrill Lynch International, J.P. Morgan Securities Ltd., NationsBanc
Montgomery Securities, Inc., PaineWebber International,
Prudential-Bache Securities (U.K.) Inc. and Smith Barney Inc., as
representatives of the International Managers. Except as provided
herein, all capitalized terms used herein which are defined in the
Purchase Agreements have the respective meanings specified therein.
With your permission, all assumptions and statements of reliance
herein have been made without any independent investigation or
verification on my part except to the extent otherwise expressly
stated, and I express no opinion with respect to the subject matter or
accuracy of such assumptions or items relied upon.

           In connection with this opinion, I have (i) investigated
such questions of law, (ii) examined originals or certified, conformed
or reproduction copies of such agreements, instruments, documents and
records of the Company, such certificates of public officials and such
other documents, and (iii) reviewed such information from officers and
representatives of the Company as I have deemed necessary or
appropriate for the purposes of this opinion.

           In all such examinations, I have assumed the legal
capacity of all natural persons executing documents, the genuineness
of all signatures, the authenticity of all original or certified
copies and the conformity to original or certified documents of all
copies submitted to me as conformed or reproduction copies. As to
various questions of fact relevant to the opinions expressed herein, I
have relied upon, and assume the accuracy of, the representations and
warranties contained in the Purchase Agreements and certificates and
oral or written statements and other information of or from public
officials and officers and representatives of the Company and others,
and assume compliance on the part of all parties to the Purchase
Agreements with their covenants and agreements contained therein.

           Based upon the foregoing and subject to the limitations,
qualifications and assumptions set forth herein, I am of the opinion
that:

           1. Each Subsidiary incorporated in the state of Delaware
(a "Delaware Subsidiary") has been duly incorporated and is validly
existing as a corporation in good standing under the laws of the
jurisdiction of its incorporation, has corporate power and authority
to own, lease and operate its properties and to conduct is business as
described in the Prospectuses; except as otherwise disclosed in the
Registration Statement, all of the issued and outstanding capital
stock of each Delaware Subsidiary has been duly authorized and validly
issued, is fully paid and non-assessable and, to the best of my
knowledge, is owned by the Company, directly or through subsidiaries,
[free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity]; to my knowledge, none of the
outstanding shares of capital stock of any Delaware Subsidiary was
issued in violation of the preemptive or similar rights of any
securityholder of such Delaware Subsidiary.

           2. To my knowledge, there is not pending or threatened
any action, suit, proceeding, inquiry or investigation, to which the
Company or any subsidiary is a party, or to which the property of the
Company or any subsidiary is subject, before or brought by any court
or governmental agency or body, domestic or foreign, which might
reasonably be expected to result in a Material Adverse Effect, or
which might reasonably be expected to materially and adversely affect
the properties or assets thereof or the consummation of the
transactions contemplated in the Purchase Agreements or the
performance by the Company of its obligations thereunder.

           3. To my knowledge, there are no franchises, contracts,
indentures, mortgages, loan agreements, notes, leases or other
instruments required to be described or referred to in the
Registration Statement or to be filed as exhibits thereto other than
those described or referred to therein of filed or incorporated by
reference as exhibits thereto.

           The opinions set forth above are subject to the following
additional qualifications:

           (A) My opinions are subject to (i) applicable bankruptcy,
insolvency, moratorium, fraudulent conveyance, and other similar laws
affecting creditors' rights and remedies generally, and (ii) general
principles of equity including, without limitation, standards of
materiality, good faith, fair dealing and reasonableness, equitable
defenses and limits as the availability of equitable remedies, whether
such principles are considered in a proceeding at law or equity.

           (B) My opinions are subject to the effect of, and I
express no opinion with respect to the application of or compliance
with, state securities or blue sky laws.

           The opinions expressed herein are limited to the federal
laws of the United States of America and the General Corporation Law
of the State of Delaware, as currently in effect. I assume no
obligations to supplement this letter if any applicable laws change
after the date hereof or if I become aware of any facts that might
change the opinions expressed herein after the date hereof.

           The opinion expressed herein is solely for your benefit
and may not be relied upon in any manner or for any purpose by any
other person or entity and may not be quoted in whole or in part
without my prior written consent.

                                                Very truly yours,


                                    By:_______________________________________
                                                  Jane E. Owens





    [Form of lock-up from directors, officers or other stockholders
                       pursuant to Section 5(i)]

                                                             Exhibit B

                                                                , 1997
MERRILL LYNCH & CO.
Merrill Lynch, Pierce, Fenner & Smith
            Incorporated,
J.P. Morgan Securities Inc.
NationsBanc Montgomery Securities, Inc.
PaineWebber Incorporated
Prudential Securities Incorporated
Smith Barney Inc.,
   as Representatives of the several
   U.S. Underwriters to be named in the
   within-mentioned U.S. Purchase Agreement
C/O  MERRILL LYNCH & CO.
     MERRILL LYNCH, PIERCE, FENNER & SMITH
     INCORPORATED
North Tower
World Financial Center
New York, New York  10281

     Re: Proposed Public Offering by The Dial Corporation

Dear Sirs:

     The undersigned, a stockholder and/or officer and/or director of
The Dial Corporation, a Delaware corporation (the "Company"),
understands that Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner &
Smith Incorporated ("Merrill Lynch") and PaineWebber Incorporated,
Prudential Securities Incorporated and Smith Barney Inc. propose to
enter into a U.S. Purchase Agreement (the "U.S. Purchase Agreement")
with the Company providing for the public offering of shares (the
"Securities") of the Company's common stock, par value $.01 per share
(the "Common Stock"). In recognition of the benefit that such an
offering will confer upon the undersigned as a stockholder and/or
officer and/or director of the Company, and for other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the undersigned agrees with each underwriter to
be named in the U.S. Purchase Agreement that, during a period of 90
days from the date of the U.S. Purchase Agreement, the undersigned
will not, without the prior written consent of Merrill Lynch, directly
or indirectly, (i) offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant for the sale of, or otherwise
dispose of or transfer any shares of the Company's Common Stock or any
securities convertible into or exchangeable or exercisable for Common
Stock, whether now owned or hereafter acquired by the undersigned or
with respect to which the undersigned has or hereafter acquires the
power of disposition, or file any registration statement under the
Securities Act of 1933, as amended, with respect to any of the
foregoing or (ii) enter into any swap or any other agreement or any
transaction that transfers, in whole or in part, directly or
indirectly, the economic consequence of ownership of the Common Stock,
whether any such swap or transaction is to be settled by delivery of
Common Stock or other securities, in cash or otherwise.

                                          Very truly yours,

                                          Signature: _______________________
                                          Print Name: ______________________





                                                               Annex A

     FORM OF ACCOUNTANTS' COMFORT LETTER PURSUANT TO SECTION 5(e)

We are independent public accountants with respect to the Company
within the meaning of the 1933 Act and the applicable published 1933
Act Regulations.

          (i) in our opinion, the audited financial statements and the
     related financial statement schedules included or incorporated by
     reference in the Registration Statement and the Prospectuses
     comply as to form in all material respects with the applicable
     accounting requirements of the 1933 Act and the 1934 Act and the
     published rules and regulations thereunder;

          (ii) on the basis of procedures (but not an examination in
     accordance with generally accepted auditing standards) consisting
     of a reading of the unaudited interim consolidated financial
     statements of the Company for the three-month periods ended March
     30, 1996 and March 29, 1997, the six-month periods ended June 29,
     1996 and June 28, 1997, and the nine-month periods ended
     September 28, 1996 and September 27, 1997 included or
     incorporated by reference in the Registration Statement and the
     Prospectuses (collectively, the "10-Q Financials") a reading of
     the minutes of all meetings of the stockholders and directors of
     the Company since December 31, 1996, inquiries of certain
     officials of the Company and its subsidiaries responsible for
     financial and accounting matters, a review of interim financial
     information in accordance with standards established by the
     American Institute of Certified Public Accountants in Statement
     on Auditing Standards No. 71, Interim Financial Information ("SAS
     71"), with respect to the 10-Q financials and such other
     inquiries and procedures as may be specified in such letter,
     nothing came to our attention that caused us to believe that:

               (A) the 10-Q Financials included or incorporated by
          reference in the Registration Statement and the Prospectuses
          do not comply as to form in all material respects with the
          applicable accounting requirements of the 1934 Act and the
          1934 Act Regulations applicable to unaudited financial
          statements included in Form 10-Q or any material
          modifications should be made to the 10-Q Financials
          incorporated by reference in the Registration Statement and
          the Prospectuses for them to be in conformity with generally
          accepted accounting principles;

               (B) at a specified date not more than five days prior
          to the date of this Agreement, there was any change in the
          common stock of the Company or any increase in the long-term
          debt of the Company or any decreases in the consolidated net
          current assets or stockholders' equity of the Company, in
          each case as compared with amounts shown in the latest
          balance sheet included or incorporated by reference in the
          Registration Statement, except in each case for changes,
          decreases or increases that the Registration Statement
          discloses have occurred or may occur; or

               (C) for the period from September 27, 1997 to a
          specified date not more than five days prior to the date of
          this Agreement, there was any decreases, in each case as
          compared with the comparable period in the preceding year,
          in the consolidated net sales or in the total or per-share
          amounts of income before extraordinary items or of net
          income, except in each case for any decreases that the
          Registration Statement discloses have occurred or may occur;

          (iii) based upon the procedures set forth in clause (ii)
     above and a reading of the Selected Consolidated Financial
     Information included in the Registration Statement and a reading
     of the financial statements from which such data were derived,
     nothing came to our attention that caused us to believe that the
     Selected Financial Information included in the Registration
     Statement do not comply as to form in all material respects with
     the disclosure requirements of Item 301 of Regulation S-K of the
     1933 Act, that the amounts included in the Selected Consolidated
     Financial Information are not in agreement with the corresponding
     amounts in the audited consolidated financial statements for the
     respective periods or that the financial statements not included
     in the Registration Statement from which certain of such data
     were derived are not in conformity with generally accepted
     accounting principles;

          (iv) we have compared the information in the Registration
     Statement under selected captions with the disclosure
     requirements of Regulation S-K of the 1933 Act and on the basis
     of limited procedures specified herein, nothing came to our
     attention that caused us to believe that this information does
     not comply as to form in all material respects with the
     disclosure requirements of Items 302, 402 and 503(d),
     respectively, of Regulation S-K;

          (v) in addition to the procedures referred to in clause (ii)
     above, we have performed other procedures, not constituting an
     audit, with respect to certain amounts, percentages, numerical
     data and financial information appearing in the Registration
     Statement, which are specified herein, and have compared certain
     of such items with, and have found such items to be in agreement
     with, the accounting and financial records of the Company.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission